protein_purity_ratio,mutation_code,seq_quality_status,sequencing_library_adapters,adapter_seq,additional_findings,adrenal_gland_function,side_effects,toxicity_grade,age_at_dx_days,age_at_diagnosis,last_age_exposure,age_of_diagnosis,age_privacy_masked,oncogene_variants,HIV_associated_conditions,clinical_metastasis_stage,clinical_n_stage,clinical_stage_group,clinical_t_stage,pathologic_m_stage,ajcc_pn_stage,pathologic_tnm_stage,tumor_stage_tnm,ajcc_version,alcohol_consumption_days_weekly,daily_alcohol_intake_units,alcohol_consumption_frequency,alcohol_use_history,alcohol_consumption_category,alcohol_consumption_type,sequencing_data_files,read_alignment_indices,genomic_data_preprocessing_steps,sequencing_alignment_tools,sample_volume_ml,sample_volume_ul,sample_types,dose_mg,study_data_files,conc_level,sample_type,biomarker_type,sample_vol_ul,biomarkers,anaplasia_status,chromosome_aberration_type,b_symptoms_presence,ann_arbor_B_symptoms,TNM_stage,ann_arbor_extra_nodal,clinical_stage,somatic_mutation_annotations,cell_marker,genomic_databases,asbestos_history,asbestos_fiber_type,avg_base_qual,avg_ins_size,seq_read_len_avg,genomic_data_reviewed,be_goblet_cells_detected,variant_calling_tool,sequencing_software_version,quality_control_status,batch_number,biorepository_code,treatment_response_outcome,sample_anatomic_location,specimen_side,cell_culture_additives,lab_test_ref_range_min,lab_test_ref_range_high,body_mass_index,bsa_m2,bone_marrow_blasts_presence,tumor_thickness_mm,burkitt_lymphoma_subtype,cancer_diagnosis_method,cancer_types,model_id,sample_issue_type,mortality_cause,death_info_source,treatment_outcome_reason,cd4_cell_count,hiv_transmission_categories,cell_num,facility_type,treatment_facilities,fluorescence_channel,carcinogenic_agents,concurrent_chemoradiation,child_pugh_score,sample_id,well_plate_location,chip_seq_ab,histone_modification,genetic_translocations,chrom_loc,chrom_arm,daily_smoking_intensity,crm_mm,clark_level_of_invasion,data_status,tumor_stage_type,nutritional_supplements,trial_participation_ind,tumor_clonality_status,coal_dust_exp,research_area_code,hepatic_cancer_stage,neuroblastoma_risk_classification,renal_stage_classification,rhabdomyosarcoma_risk_classification,columnar_epithelium_status,coexisting_conditions,diagnosis_method,concentration_mM,consent_type_alt,path_review_status,contamination_level,sample_contam_pct,direct_invasion_organs,cnv_count,CNV_supporting_documents,structural_variant_liftover_methods,cnv_segments,CNV_detection_methods,birth_country,enrollment_country,treatment_cycle_no,record_timestamp,sample_timestamp,author,body_weight_kg,chromosomal_location,data_type,file_type,file_types,cancer_biomarkers,data_category,biomarker_types,time_to_ae_days,time_to_response_d,age_at_diagnosis_days,time_to_sample_collection_days,time_to_comorbidity_days,time_to_consent_days,survival_days,time_to_diagnosis_days,time_to_event_days,follow_up_duration_days,time_to_scan_days,time_to_disease_status_change,time_to_pathology_report_days,time_to_disease_progression,PFS_days,time_to_tumor_recurrence_days,time_to_exposure_years,time_to_seq_days,time_to_test_days,treatment_duration_days,time_to_treatment_initiation_days,study_accession_id,patient_background,associated_data_types,diabetes_medication_type,is_primary_tumor,pathological_diagnosis_confirmed,non_contig_lesion_num,treatment_outcome,cancer_type,tumor_margin_distance,supplier_id,pulmonary_diffusion_capacity_pct,publication_id,DE_lymphoma_status,double_hit_lymph_status,treatment_type,dysplasia_severity,dysplasia_type_alt,ecog_ps,educational_attainment,aml_risk_group,embolization_material,sequencing_quality_score_format,enneking_stage,m_stage_classification,musculoskeletal_tumor_stage,metastasis_stage,lymph_node_status,ETS_exposure_status,epithelial_cell_percentage,data_integrity_issues,esophageal_dysplasia_severity,esophageal_barretts_metaplasia_status,race_ethnicity,progression_evidence_type,recurrence_confirmation_type,weekly_exercise_freq,gene_segments,study_protocol_docs,study_type,sample_preparation_method,research_methods,assay_type,exposure_time,daily_exposure_hrs,exposure_time_yrs,exposure_type,risk_factor,risk_factors,bioinformatics_pipelines,extracapsular_spread,extracapsular_spread_status,extranodal_ext_status,extrascleral_ext,thyroid_extension_status,iris_pigmentation,FAB_classification_code,cancer_family_history,seq_file_name,post_bronch_fev1_fvc_ratio_percent,pre_bronch_FEV1_FVC_ratio_percent,post_bronchodilator_fev1_pct,predicted_fev1_pct_pre_bronchodilator,cancer_stage,figo_version_year,sample_data,data_size_bytes,dataset_resources,outcome_status,initial_symptom_duration_days,initial_symptoms_pre_diagnosis,sequencing_batch_id,patient_outcomes,read_length_max,avg_fragment_len,min_frag_len,frag_std_dev_len,restriction_enzyme,cryopreservation_technique,GE_junction_involvement_status,sex,gene_expression_profiles,gene_id,genomic_data_processing_steps,germline_variant_detection_methods,gleason_score_category,gleason_pattern_tertiary,gleason_score_percentage,gleason_grade,columnar_epithelial_cells_mucosal_presence,max_tumor_diameter_cm,tumor_mass_g,tumor_growth_speed,antiretroviral_therapy_status,body_height_cm,hepatitis_sv_response,tumor_grade,histone_type,tumor_history_status,tumor_history_type,hiv_vl_log_copies_ml,contraceptive_hormone_type,contraceptive_status,HRT_type,hpv_strain,human_papillomavirus_type,hyst_margins_involved,hysterectomy_status,icd10_codes,cancer_type_icd10,patient_id,international_germ_cell_cancer_stage_grouping,anatomic_location_imaged,scan_date,imaging_outcomes,imaging_outcome,pet_suv_values,max_suv_values,imaging_modality,immunosuppressive_medication_type,under_review,contains_spike_additions,event_date,disease_status_at_onset,initial_wt_kg,histology_classification,inrg_classification,sequencing_technology,planned_publication_date,tumor_size_mm,IPI_score,int_regions,irs_classification,irs_stage_alternative,ffpe_status,is_deprecated,hepatic_fibrosis_stage,performance_score_kps,sequence_quality_check,clinical_biomarkers,lane_id,extrapelvic_peritoneal_involvement_size,current_disease_status,side_of_lesion,record_creation_timestamp,last_modified_timestamp,num_lesions_treated,cancer_data_sources,library_prep_kit_cat_no,seq_lib_prep_kit,seq_kit_manufacturer,seq_lib_prep_kit_ver,library_prep_method,RNA_seq_library_orientation,sequencing_technique,abnormal_loci_count,num_of_loci,gene_chromosome_location,max_tumor_diameter,follow_up_status,lymph_node_dissection_type,lymph_node_excision_location,lymph_node_sites,positive_lymph_node_count,num_lymph_nodes_examined,lymph_invasion_status,optical_zoom_level,version_num,tumor_margin_dist_mm,tumor_margin_status,tumor_invasion_sites,relationship_status,masaoka_karnofsky_stage,cg_methylation_status,genetic_variants,primary_tumor_location,file_hash,avg_seq_depth,measurement_unit_abbr,medulloblastoma_subtype,primary_melanoma_status,menopausal_status,metaplastic_status,metastatic_status_at_diag,initial_metastatic_sites,sample_collection_method,DNA_methylation_data_processing_steps,DNA_methylation_levels,methylation_conversion_protocols,micromet_status,micropap_features,minor_rel,miRNA_detection_methods,microRNA_expressions,MMR_status,cell_death_rate_index,mitotic_rate,mitotic_area_total,genetic_testing_technique,variant_effect,genetic_biomarkers,tumor_growth_pattern,histology_code,microsatellite_instability_score,microsatellite_instability_status,mutation_position,MG_severity_scale,lowest_cd4_count,genomic_feature,institution_domain,tumor_necrosis_pct,tumor_necrosis_status,no_normal_match_lp_wgs,lacks_control_tumor_seq,lacks_matched_normal_sample,lacks_matched_normal_WXS,extranodal_extension_status,non_cancer_drugs,genotype_snp_comparison_status,clinical_observations,expected_cell_count,cycles_count,total_dose_fractions,cell_proliferation_count,work_experience_yrs,job_title,OCT_Embedding_Status,additional_clinical_features,ovarian_capsule_status,ovarian_involvement_status,oxygen_utilization_flag,oxygen_admin_mode,smoking_history_pack_years,translocations_diff_chromosomes,pancreatitis_diagnosis_year,prcc_subtype,specimen_types,radiation_exposure_in_parents,cell_line_passage_no,variant_clinical_significance,path_report_id,pediatric_renal_staging,nucleotide_quality_score,base_seq_quality_score,seq_quality_score,gc_content_quality,tile_seq_qual_status,eosinophil_percent_infiltration,follicular_ratio_percentage,gc_content_pct,percent_neutrophil_infiltration,tumor_inflam_infiltrate_pct,tumor_lymphocyte_percentage,monocyte_percentage_in_tumor,neutrophil_percentage_infiltrate,percent_viable_cells,percent_rhabdoid_component,sarcomatoid_percentage,stromal_cell_percentage,tumor_cell_percentage,tumor_invasion_percentage,tumor_nuclei_percentage,PNI_status,peripancreatic_LN_metastasis_count,peripancreatic_LN_examined,peritoneal_fluid_cytology_result,peritoneal_cytology_status,test_panel,well_id,sequencing_technologies,cell_ploidy_status,pubmed_id,daily_servings_intake,parity_count,pregnancy_outcomes,pregnancy_status_at_dx,preterm_birth_status,administered_dose,sample_storage_type,primary_dx,primary_diagnosis,gleason_score_primary,cancer_site,previous_cancer_history,previous_treatment_status,proc_type,medical_procedures,cancer_research_areas,disease_outcome_status,metastasis_location,disease_progression_type,research_focus_area,study_identifier,research_topics,base_mismatch_rate,depth_coverage_10x_pct,coverage_pct_30x_depth,duplication_rate,mapping_efficiency,uncovered_target_ratio,prostate_biopsy_positive_cores,prostate_biopsy_core_count,prostate_involvement_pct,oncogene_markers,study_id,ethnicity,radiosensitizer_use,radon_exp,methylation_platforms,read_group_metrics,sequencing_platforms,seq_length_bp,read_pair_type,treatment_non_admin_reason,lesion_count_recist,total_lesion_measurement_cm,GERD_treatment_category,treatment_line_or_type,associated_documents,age_at_dx,sex_at_birth,primary_diagnosis_type,family_relationship_type,family_history_deceased,family_smoking_status,family_cancer_history,family_cancer_history_count,is_public,publication_date,data_release_flag,publication_status,submission_status,surgical_margin_status,residual_disease_status,residual_tumor_size,RCS_exposure_status,version_number,rhabdoid_tumor_percentage,rhabdoid_feature,rRNA_28S_to_16S_ratio,relative_immunonegativity_index,treatment_associated_risk,cancer_risk_factors,transcriptomics_techniques,rna_quality_score,cancer_cell_types,admin_route,experimental_data_files,sample_num,sample_classification,specimen_type_code,sarcomatoid_ratio,sarcomatoid_features,satellite_lesion_status,radiotracer_type,data_version,exon_2_position,alternative_gene_symbols,molecular_characterization_techniques,secondary_gleason_score,passive_smoking_exposure_in_childhood,tumor_site,normal_sample_low_quality_wgs,normal_tissue_genotyping,normal_sample_included_wgs,normal_sample_wxs_selected,seq_duplication_rates,seq_len_dist_quality,sequencing_facility,sample_date,institution_acronym,min_dimension,germline_mutations,genomic_alterations,single_cell_technology,anatomic_site_of_origin,metastasis_locations,num_sites_involved,extranodal_mass_size_cm,particle_size_distribution,histopathology_images,slide_types,smoking_status,somatic_variant_calling_methods,somatic_variant_callers,CNV_analysis_methods,cancer_variant_calling_methods,gene_variant_codes,molecular_diagnostics_tests,protein_quantification_method,spike_ins_conc,control_sequences_fasta,spindle_cell_percentage,stain_method,immunohistochemistry_score,sample_issue_desc,approval_status,sv_detection_methods,genomic_alterations_detected,genotyping_platforms,methylation_level_beta_values,cnv_ratios,unaligned_reads_bams,participant_identifier,brain_tumor_location,concurrent_malignancy,gene_panel_id,exon_capture_kit_id,exome_capture_kit,seq_capture_kit_manufacturer,exome_capture_technology,biomarker_status,alternative_measurement_units,biomarker_level,tumor_marker_percentage_range,treatment_options,treatment_efficacy_achieved,therapeutic_target_concentration,ischemia_time_min,excision_to_freezing_duration_min,time_to_first_cigarette,treatment_phase,tma_coords,primary_site,sample_origin_sites,adapter_seq_trim_flag,smoking_initiation_year,smoking_cessation_year,total_seq_reads,total_seq_count,gene_transcript_id,transglottic_involvement,treatment_site,treatment_sites,treatment_protocol_id,max_dose_administered,dosage_units,treatment_length_days,treatment_response,dosage_interval,treatment_purpose,treatment_status,treatment_response_duration_days,therapy_type,cancer_treatment_methods,tumor_load,disease_type,cancer_type_code,organ_confined_status,tumor_thickness,tumor_invasion_depth,tumor_type,tumor_multiplicity,tumor_classification,tumor_grade_system,TIL_density,TAM_density,tumor_size_cm,prostate_tumor_zone,tumor_ploidy_level,tumor_cellularity,tumor_response_grade,tumor_morphology,tumor_depth_mm,tumor_diameter_cm,data_release_type,exposure_type_smoke,smoking_type,tnm_stage,tnm_tumor_stage,ajcc_clinical_stage,pathologic_stage_t,uicc_stage_ed,ulceration_status,cryptorchidism_status,cryptorchidism_repair_age_months,cryptorchidism_side_corrected,cryptorchidism_treatment_type,cryptorchidism_side,last_modified_dt,daily_usage_freq,mutation_origin,mutation_type,vascular_invasion_status,hepatitis_viral_markers,patient_outcome_status,gestational_age_weeks,weiss_criteria,weiss_score,plate_position,genome_seq_depth,cns_grade_classification,wilms_tumor_grade,workflow_completion_dt,workflow_repo_url,process_initiation_timestamp,analysis_method,pipeline_version,birth_year,death_year,diagnosis_year,follow_up_duration_yrs,smoking_duration_years,prostate_zone_origin,allele_status
1.85,BRAF_V600E,Failure,Illumina_Adapter,P7_adapter,Ferruginous_bodies,Absent,Loose Stools,G1,20_years,infant,adolescent,pediatric,1,TP53_variants,Valley_fever,M0,N0,Stage_0,T1b,M0,N0_mol_neg,NR,T1a,I,zero_days,none,Daily,No,Regular_Drinker,Beer,Tumor_Sample1_Read1.fastq.gz,S1_23456,Align_Optimization,Burrows-Wheeler_Align,1500ul,50ul,Frozen_tumor_biopsy,0.1g,gene_expr_summary.csv,2.5ng/mL,Aberrant,Deoxyribonucleic_Acid,50ul,BRCA1_gene,None,Monosomy_X,Absent,Pyrexia,NR,No,Stage_1,G12D_KRAS,CD14_Monocyte_Differentiation_Antigen,TCGA,Absent,Grunerite,thirty-five point two,150bp,75bp,Yes,Absent,Illumina_BSP,Guppy_v4.0.11,Failure,B101,AB01,AJ-Adj_Therapy,Dorsum,Bilat,FBS,RBC_min,hemoglobin_upper_limit,underweight,1.52_m2,Absent,0.5_mm,Endemic_BL,Not_Reported,IDC,HCM1_123,BCR_Notif,Neoplastic_Causes,Postmortem_Examination,AE,four_hundred_fifty,Coagulation_Disorder,1K,Comprehensive_Cancer_Centers,MDACC,FAM,Chrysotile,No,A,RG001_PT_A_TMR,A01-1,NA,H3K27acetylation,Not_Reported,Not_Reported,NR,non-smoker,10mm,level_1,invalid,Not_Collected,Cholecalciferol,False,Monoclonal,Absent,CRS-23-01,NR,High_Risk,NR,high_risk,No,Chronic_Pancreatitis,Biochem_Assessment,50uM,Exemption,N,0.1%,2%,Adrenal_Gland,zero,CNV_report_pdf,GATK4_CopyNumberVariation,gain,WGS Analysis,Antigua_and_Barbuda,AD,cycle_1,2023-01-15T14:30Z,2021-03-01 00:00:00,Susan O'Reilly,45.5kg,1q21,Clinical_Data,Array_Data_Format,Sequence Alignment/Map Format,ER+,Somatic_Mutation_Summary,Genome_Seq_Data,5d,2_weeks,-9 years,immediate,baseline,immediate,DOD_0,0_days,1_week,NA,day_1,negative_infinite,immediate,1.5_months,1.5_months,1.5_months,-1,baseline,3_days,4_weeks,0_days,PHS000424,Age,DNA_Sequence_Data,Metformin,1,No,none,DU-Unchanged,Mixed_Stromal_Tumors,Proximal_<=2cm,SUPP-00123CA,eighty-five,nrc2017104,Absent,Negative,Corticosteroid,High_Grade,Epithelial_Dysplasia,0_Fully_Active,Bachelors_Degree,High_Risk,Gelatin_Sponge,Sanger_seq,Not_Rptd,M0,E2,M0,Absent,Absent,5.2%,format_error,High_Grade_Dysplasia,No,Unknown,Imaging_Evidence,Biopsy_Histologic_Confirmation,1-2_days,segment1,sample_preparation_protocol.pdf,CellGrowthAssay_HD33,RNA_Isolation,Transcriptomics,ATAC-seq,Not_Reported,0.5h,1_year,Domestic,Asbestos,Alcohol_Related_Liver_Disease,RNA_seq_data_analysis,Ext,Absent,Gross_Ext,Present,T3_Minimal,Amber,M0_Acute_Myeloblastic_Leukemia_Minimal_Maturation,Mammary_cancer,s1_read1_001.fastq,75.2%,72.5%,seventy-five,seventy-two,Stage_I,'88,BRCA1_gene_sequence.fasta,0.5KB,BRCA1_gene_sequence.fasta,Alive,0-30D,Cognitive_Impairment,SEQ12345X6,Initial_dx,150bp,two_hundred_bp,100bp,35.2_SD,MboI,Immersion in liquid nitrogen,No,F,BRCA1_overexpression,ARNTL,WGS_Alignment,GATK_Best_Practices,G1,P4,5%,low_grade,Absent,1.2_cm,45200,24_hrs,No,1.5m,No_Response,G1,centromere_protein_A,Absent,Colorectal_Ca,less_than_50_copies_ml,NR,Active,Estrogen_mono,HPV-26,HPV-16,Urinary_Bladder,Hysterectomy_UNSPEC,Malignant_neoplasm_of_breast_unspecified,Malignant neoplasm of breast unspecified,patient_root,Favorable,Mammary,2023-Jan-15,Peritoneal_Carcinomatosis,Indeterminate,low,2.5,Ultrasound,TNF_inhibitor,1,Yes,Dx,Initial_Dx,45.2_kg,Favorable_Prognosis,Localized_1,Affy_SNP6,2023-Jul-15,25mm,High_Risk,int_1,Group_2,stage_1,Formalin-Fixed,Yes,0_None,10_dead,Failure,Leukocyte_Blast_Percentage,L1,macro_<=2cm,Biochemical_recurrence,Bilat,2015-03-12T08:47:30+00:00,2021-03-15T14:30Z,single,Oncogene_Exp,NEB E7645,Illumina TruSeq Stranded mRNA,Illumina Inc.,TruSeq RNA Library Prep Kit v2,Affinity_Capture,FS,Transposase-Accessible Chromatin Sequencing,zero,single,BRCA1_17q21.31,2.5cm,Not_Followed_Up,FND,Cervical,Cervical,zero,zero,Absent,40x,v1,0.1_cm,Indeterminate,Gerotas_Fascia,Dissolved,Stage_1,CGI_1001_Methyl_Inc,G12D_KRAS,Maxillary,e4da3b7fbbce2345d7772b0674a318d5_hash,30_fold_coverage,cm,Non-WNT/Non-SHH,Absent,NR,Absent,distant_met,Peritoneal_Effusion,Prospective_Collection,Bisulfite Seq QC,high,Bisulfite_Sequence_Liftover,Absent,Absent,v1,miRNA_sequencing,hsa-miR-21,No,High,low,1.5k,Chromosomal_analysis,UTR5_Variant,BRCA1/2 gene analysis,Cohesive_cluster,neoplasm_benign,low,Microsatellite_instability,c.35G>A,I_Minimal,fifteen,Loss_of_Heterozygosity,mdacc.org,0.5%,Absent,Absent,Absent,Absent,Yes,Absent,Paracetamol,Absent,Metastatic evidence observed,one_hundred,single,single,fifty,1_year,Physician,Yes,Grade_of_Tumor,Not_Reported,Absent,No,Continuous_Oxygen_Therapy,none,one_twenty,1998,Type_I,Neoplastic_tissue_biopsy,Absent,P1,benign,4f12bc9e-6f4c-8eba-17e3-1a6432f347,tumor_confined_kidney_with_distant_metastasis,Failure,Failure,Failure,Failure,FAILURE,2.5%,5.2%,forty_percent,2.5%,12.5%,2.5%,2.5%,2.5%,98.5%,none,0%,5.2%,0.5%,5.2%,5.2%,Absent,0,zero,Atyp,Neg,BRCA1_Seq_Analysis,A1,HiSeq,Aneuploidy,PMID_25468954,0-1_servings,nulliparous,Tubal_Pregnancy,No,No,50mg,Cryo,Meningioma,Yes,G1,Anal_Canal,Data_Not_Collected,No,DNA_seq_skipped,Colorectal_Screening,Early Detection & Screening Programs,No,Vestibulocochlear_nerve,Biochemical_Recurrence,Oncogene_Research_Initiatives,CRS-2023-01_ALT,Proto-oncogene_Activation,0.2%,95%,95%,8%,95%,2%,zero,twelve,0%,ERBB2,P321P2,AI_AN,Absent,Absent,Illumina_450K,Avg_Base_Quality,HiSeq_2500,50bp,NA,Adverse_Events,single,25mm,Antacid_Therapy,1st_line_chemo,gene_expr_datasets.csv,thirties,F,Urothelial_Carcinoma,Foster_Sibling,No,Non-smoker,absent,zero,Yes,2023-Jan-15,1,Published,Enabled,NR,R0_no_residual_tumor,<10_mm,Absent,v1,0%,Absent,high,10,Absent,Tobacco_use,Bulk_Sequencing,perfect,Primary_tumor,PO,aligned_reads.bam,first,Benign_Tumors,primary_tumor,none,Absent,None,Ac,1.0,Ex2,ERBB3_HER3,Gene_expression_analysis,Grade_1,Absent,Mammary,Yes,Yes,Included,Yes,Failure,Failure,Broad Inst,2021-Mar-15,UTMDACC,2.5_cm,BRCA1_var,Del,Chromium_3p_GEX_v2,Gastroesophageal_junction,Lymphatic_system,single,2.5_cm,<10nm,Hematoxylin_and_Eosin_stained_lung_cancer,Hematoxylin_and_eosin_stain,2:Former_Smoker_<15yrs,MuTect2,MuTect2,GISTIC_2,MuTect2_GATK,G12D_KRAS,Telomerase_Activity_Test,UV-Visible_Spectroscopy,500 pM,ERCC.fasta,5.2%,H_and_E,neg,Contaminated_sample,Authorized,MantaSV,BRCA1_mutational_analysis,Affymetrix SNP 6.0 Array,0.856,gain,SRR1234567_unaligned.bam,BGX23_SA,Cerebrum,No,GENIE_DFCI_447,TC1001-SureZyme,Agilent_SureSelect_All_Exon_V6,Agilent,SureSelectXT_Human_All_Exon_6,Aberrant,Not_Reported,2.5_ng/mL,0-25,A2A Receptor/Phosphodiesterase-10A Inhibitor PBF-999,Absent,>14_mg_per_L,2_minutes,5_min,31-60_min,Adj_Therapy,A01-1,Epiglottis_anterior_surface,Pulmonary,Yes,Y1970,1985,1e5,one_k_two_four,ENST00000367770,None,Axillary,Mammary,A081105_ALT,50mg,IU_per_kg,4_weeks,CR_Complete_Response,q24h,Adjuvant_Therapy,no_treatment,1.5_months,Anticonvulsant_Therapy,Chemo,0.5_cm3,ALAL,carcinoma,N,1.2_mm,1.2_mm,NOS,Multicentric,G2,Grade_4,Sparse,Low,2.5_cm,Peripheral_zone,haploid,95%,0_Complete_Response,Infiltrative,0.5_mm,2.5_cm,publication_version,Unintentional_fire_smoke,Cigarillo,Stage_1A,T0,Stage_1A,NR,I,Absent,Absent,0.5_years,Bilat,Hormonal_Therapy,Bilat,2023-01-15T14:30Z,none,Germline_variant,Allelic_Variants,EMVI,Anti-HBc,Alive,preterm_early,Nuclear_grade,absent,A1,no_coverage,G1,Favorable_Histology,2023-07-15T14:30Z,https://github.com/cancer-genomics/workflow_v1/commit/a1b2c3d4e5,2023-01-15T08:30Z,ABSOLUTE_LiftOver,v1.0.0,MCMII,Y2015,Y2005,Y1,0,CZ,Hemizyg
1.9,KRAS_G12D,NR,Nextera_Adapter,P5_adapter,Endometriosis_with_adhesions,NR,Xeroderma,G2,40_years,toddler,young_adult,adolescent,0,KRAS_variants,Filobasidiella,M1,N0_molecular_positive,Stage_IA2,T2a,M1a,N1a,Tis_N0_M0,T1b,II,one_day,light,Weekly,NR,Frequent_Drinker,Spirits,Tumor_Sample1_Read2.fastq.gz,S2_78901,Species_Contaminant_Cleaning,Bowtie_2,2000ul,100ul,FFPE_tumor_biopsy,0.2g,mutational_burden_analysis.xlsx,4.0ng/mL,Healthy,NR,100ul,BRCA2_gene,Generalized,Triple_X,Data_Not_Collected,Diaphoresis_nocturnal,I,Data_Not_Collected,Stage_2,R175H_TP53,CD15_Lewis_X,GDC,NR,Riebeckite,twenty-eight point seven,200bp,100bp,No,NR,GATK_HC,Albacore_v2.3.4,NR,B202,CD02,IPD-Immune_Progression,Cholangio,L,Collagenase Type IV,Na_min,WBC_count_max,normal_weight,1.63_m2,NR,0.8_mm,ID-associated_BL_adult,Early_Detection,DCIS,HCM1_456,Specimen_ID_unknown,Cardiovascular_Diseases,Vital_Records,Treatment_Completion,five_hundred_sixty,Heterosexual_Exposure,5K,Basic_Research_Facilities,MSKCC,VIC,Benzol,NR,B,RG002_PT_A_NRM,B02-5,Unknown,H3K27trimethylation,NR,Unknown,short_arm,occasional_smoker,15mm,level_2,deprecated,Pre-cancerous,Eicosapentaenoic Acid and Docosahexaenoic Acid,NR,Polyclonal,Not_Determined,ONC-23-02,I,Intermediate_Risk,I,intermediate_risk,Not_Reported,Liver_Cirrhosis,Clinical_Biochem_Assessment,100uM,Waiver,NR,0.5%,5%,Urinary_Bladder,one,segmented_data_xlsx,BroadGenomics_CGH_Liftover,gain,Targeted DNA Sequencing,PRC,AW,cycle_2,2023-02-20T09:15Z,2021-03-02 00:00:00,James P Allison,68.2kg,3p14,CNV,Bioinformatics_Cancer_Research_table,Binary Alignment/Map,HER2+,Sequence_Alignment_Index,RNA_Seq_Data,12d,4_weeks,-18 years,next_day,2_weeks,next_day,DOD_45,1_week,2_weeks,1.5_months,day_3,negative_long_term,next_day,2_months,2_months,3_months,-2,day_1,1_week,6.5_weeks,1_day,PHS000425,Sex,Pathology_Images,Lifestyle_Modification,0,Data_Not_Collected,single,Non-CR_Non-PD-Stable Disease,Mucinous_Serous_Neoplasms,Remote_>2cm,SUPP-00234BC,ninety-two,ccr-18-2367,NR,NR,Cytokine,Low_Grade,Esophageal_Columnar_Dysplasia,1_Restricted_in_Physically_Strenuous_Activity,Secondary_Education_Completed,Low_Risk,Ethiodized_Oil,Illumina_v1.5,IA,NR,I1,M1,NR,Not_reported,12.7%,size_mismatch,Indeterminate_Dysplasia,NR,Hispanic_Latino,Pathological_Confirmation,Imaging_Evidence,3-4_days,segment2,data_acquisition_methods.docx,CellDeathRate_MCF7_CDDP,DNA_Isolation_Chemical_Method,WGS,ChIP-seq,>=6_Weeks,1h,2_years,Work_related,Chemical_Exposure,Food_Allergy,Diff_gene_expr_analysis,Foc,Not_Assessed,Micro_Ext,Absent,T4a_Moderate_Advanced,Azure,M1_Acute_Myeloblastic_Leukemia_Without_Maturation,Colorectal_neoplasms,s1_read2_001.fastq,68.9%,68.9%,eighty-nine,eighty-five,Stage_II,'95,Tumor01_sample.bam,1KB,MRI_images.dcm,Deceased,31-90D,Cephalalgia,SEQ23456Y7,3mo_followup,200bp,two_fifty_bp,150bp,47.8_SD,NA,Dimethyl sulfoxide cryopreservation,NR,M,TP53_suppression,BMP5,Variant_Calling,Mutect2_tumor_only_mode,G2,P5,10%,intermediate_grade,NR,0.8_cm,88900,30_hrs,NR,1.62m,NR,G2,H2A_barrel_domain_binding,NR,LGG,50_copies_ml,Prog,Past,NR,HPV-33,HPV-18,Macro_Parametrium,Not_Performed,Malignant_neoplasm_of_upper_lobe_bronchus_or_lung,Malignant neoplasm of upper lobe bronchus or lung,pt_root,Intermediate,Pulmonary,2023-Feb-20,Renal_Metastasis,Neg,moderate,4.1,Histologic,Azathioprine,0,No,First_Pt_Visit,NR,30.5_kg,NR,Localized_2,CG,2023-Sep-01,48mm,High_Intermediate_Risk,int_2,Group_3A,stage_2,Fresh,No,1-2_Portal_Fibrosis,100_normal,Not_Available,Circulating_Tumor_Cells,L2,macro_>2cm,Distant_metastasis,L,2016-07-26T14:22:15+00:00,2022-06-20T09:15Z,double,Tumor_Suppressor_Seq,KAPA KK8504,New England Biolabs NEBNext Ultra II DNA,Thermo Fisher,Nextera XT Library Prep Kit v2.5,Sequence_Capture,NA,Chromatin Immunoprecipitation Sequencing,one,double,TP53_17p13.1,4.8cm,Not_Applicable,MRND,Left_axillary,Lateral_axillary,one,one,NR,100x,v2,0.5_cm,Positive,Kidney_Parenchyma,Cohabiting,Stage_3,CGI_2045_Methyl_Dec,R175H_TP53,Mediastinal_nodes,1679091c5a880faf6fb5e6087eb1b2dc_hash,60_fold_coverage,mm,ND,NR,Peri-menopausal,NR,met_nos,Renal,Retrospective_Collection,Inter-platform Data Harmonization,moderate,Whole_Genome_Bisulfite_Sequencing_to_hg38,NR,NR,v2,quantitative_RT-PCR,hsa-miR-155,NR,Moderate,moderate,2.3k,Unspecified,CDS_Variant,EGFR gene mutation analysis,Cribriform,carcinoma_nos,intermediate,Microsatellite_stable,c.37G>A,II_Mild,thirty_two,Microsatellite_Instability,msk.org,2.3%,NR,Present,Present,Present,No,NR,Acetylsalicylic_Acid,Collection_Prohibited,Elevated aggressive biomarkers,two_hundred,double,five,one_hundred_twenty,3_years,RN,No,Presence_of_Lymphovascular_Invasion,Capsule_Fragmented,Indeterminate,NR,On-Demand_Oxygen_Therapy,less_than_half,four_fifty,2001,Type_II,Peripheral_blood_sample,NR,P2,likely_benign,5e2fbc8a-594e-c98b-242a-8b8f4fd7e6,tumor_confined_kidney_no_distant_metastasis,NR,NR,NR,NR,NR,7.8%,12.7%,forty_two_percent,7.8%,23.8%,7.8%,7.8%,5.0%,95.2%,minimal,5%,12.8%,2.3%,12.7%,12.8%,NR,1_to_3,one,Benign,NR,LungCancer_Gene_Panel,B2,GeneChip,Diploidy,PMID_26786412,2-3_servings,primiparous,Termination_of_Pregnancy,NR,NR,100mg,Ethylenediaminetetraacetic_acid,atypical,No,G2,Central_Nervous_System,absent,Data_Not_Collected,DNA_sequencing_omitted,Gastrointestinal_Scopy,Cancer Immunotherapy Studies,Not_Collected,Abdominal_soft_tissues,Metastasis,Immuno-oncology_Clinical_Trials,ONCO-GEN-09_ALT,Antioncogenes,0.5%,87%,98%,12%,89%,5%,one,eighteen,5%,ERBB1,NCT003881,Asian,NR,NR,Illumina_27K,Total_Read_Cnt,PGM,75bp,Read1,Physician_Decision,double,48mm,Histamine2_Receptor_Antagonists,2nd_line_chemo,demographic_info.xlsx,forties,M,Brain_Cancer,Full_Sibling,NR,Unknown,nr,one,No,2023-Feb-20,0,Not_Published,Disabled,No_Residual_Tumor,R1_microscopic_residual,10-20_mm,Not_reported,v2,5%,NR,above_average,9.5,NR,Ethanol_use,scRNA_Sequencing,excellent,Secondary_tumor,IV,qc_metrics.json,second,Bone_Marrow_Cancer,recurrent_tumor,minimal,Not_Available,Uncertain,F-18 Fluciclovine,1.2.3,Ex5,FES_FPS,Proteomics,Grade_2,NR,Pulmonary,No,No,Excluded,No,NR,NR,Genentech Inc,2021-Jul-22,DANA-FARBER,1.2_cm,BRCA2_var,Dup,Chromium_3p_GEX_v3,Not_Otherwise_Specified,Hepatic,double,4.1_cm,10-30nm,IF_labeled_breast_cancer,IF_staining,3:Active_Smoker,VarScan2,Strelka2,ABSOLUTE,VarScan2,R175H_TP53,CTC_Analysis,NanoDrop_Spectrophotometer,1000 pM,SIRV.fasta,12.8%,IHC,weak,Low_volume,Revoked,DellySV,TP53_mutation_screening,Illumina OmniExpress,0.342,normal,SRR7654321_unaligned.bam,OLab45_TB,Basal_ganglia,NR,MSK_IMPACT_468,TCK2580-GeneLock,Illumina_TruSeq_Exome,Roche,TruSeq_Exome_v3,Not Specified,ug/gHb,7.8_ng/mL,26-50,XmAb2513,NR,above_14_mg/L,5_minutes,10_min,6-30_min,End_Consol_Therapy,B02-5,Anal_canal,Mammary,No,Y1982,1990,2.5e5,two_k_fifty_six,NM_007294,NR,Cerebellar,Pulmonary,A081801_ALT,100mg,grams_per_day,6.5_weeks,MR_Mixed_Response,q1h,Hormone_Therapy,not_specified,3_months,Excisional_Biopsy,X-ray therapy,1.2_cm3,AML,sarcoma,NR,3.5_mm,3.5_mm,New_Primary,NR,G3,Not_Reported,Abundant,High,4.8_cm,Transition_zone,diploid,85%,1_Partial_Response,Convex,0.8_mm,4.8_cm,dataset_version,Cooking_fumes,Traditional_Cigarette,Stage_1A1,T1a,Stage_1A1,TX,II,NR,NR,1_year,Lt,NR,L,2023-02-03T09:15Z,once,Acquired_variant,Gene_Conversion,IMVI,Hepatitis B Virus DNA,Deceased,preterm_late,Mitoses_per_50HPF_>5,very_low,B2,low_coverage,G2,NR,2023-08-22T09:45Z,https://github.com/genome-research/workflow_v2/commit/f6g7h8i9j0,2023-02-20T09:45Z,Ascat_NGS,v1.2.1,MCMVI,Y2016,Y2006,Y2,1,OMZ,Heterozyg
1.95,EGFR_T790M,Successful,TruSeq_Adapter,Index_adapter,Hematopoietic_tissue_concordance,Present,Peptic Ulcer,G3,22_years,preteen,adult,young_adult,Y,APC_variants,Crypto,M1a,N1b1,Stage_IB2,T2b,M1b,N1b,T1a_N0_M0,T2a,III,two_days,moderate,Monthly,U,Abstainer,NR,Normal_Sample1_Read1.fastq.gz,S3_34567,PCR_Artifact_Minimization,Spliced_Transcripts_Alignment_to_a_Reference,500ul,150ul,Plasma,0.3g,patient_info.json,1.2ng/mL,NA,Protein,150ul,Prostate_Specific_Antigen,Indeterminate,XXY,NR,Additional_symptoms,II,NR,Stage_3,V600E_BRAF,CD20_B-Lymphocyte_Antigen,Oncomine,U,Grunerite,thirty point four,250bp,125bp,0,NA,Google_DeepVariant,Bonito_v0.3.6,Successful,B303,EF03,MR-Min_Response,Vesica Urinaria,NR,Trypsin-EDTA Solution,K_min,fasting_glucose_upper,overweight,1.74_m2,U,1.0_mm,ID-associated_BL_pediatric,Monitoring,LCIS,HCM1_789,QC_Failure,Not_Otherwise_Specified,Health_Record,Deceased,three_hundred_twenty,MSM,10K,Clinical_Research_Facilities,JHSKCCC,VIC,Methanal,U,C,RG003_PT_B_TMR,C03-10,H3K27ac_antibody_ab4729,H3K36trimethylation,translocation_10_11_p11.2_q23,11q,long_arm,light_smoker,20mm,level_3,checksum_in_progress,Initial_primary,Live Cultures,True,Monoclonal,Present,GENO-23-03,II,Low_Risk,II,low_risk,Unknown,Idiopathic,Clinical_Assessment,250uM,Death_Related,Y,1%,10%,Large_Intestine,two,CNV_presentation_ppt,Pindel_SVLiftover,gain,CGH Analysis,Denmark,BZ,cycle_3,2023-03-05T16:45Z,2021-03-03 00:00:00,Elizabeth Blackburn,70.1kg,5q35,Copy_Number_Var,Browser_Extensible_Data_Paired_End,Variant Call Format,TNBC,CNV_Segments,Protein_Expression_Data,18d,6_weeks,-12 years,3_days,1_month,two_days,DOD_90,2_weeks,3_weeks,3_months,week_1,negative_2_years,3_days,3_months,3_months,4_months,-3,day_3,2_weeks,8.6_weeks,3_days,PHS000426,Race_Ethnicity,Clinical_Study_Findings,Exogenous_Insulin,Yes,NR,double,NR-Not Reported,Fibroma_Related_Tumors,NR,SUPP-00345LC,seventy-eight,cell201802065,Present,Positive,Poly_ADPRibose_Polymerase_inhibitor,Mild,Esophageal_Mucosa_Dysplasia,2_Ambulatory_and_Capable_of_all_Selfcare_but_Unable_to_Carry_out_Work_Activities,Unreported,Intermediate_Risk,Other_Agents,Illumina_v1.8,IB,M1,NR,M1a,Present,Present,18.9%,checksum_failure,Low_Grade_Dysplasia,Unknown,Not_Collected,Imaging_Evidence,Histologic_Confirmation,5+_days,segment3,control_grp_info.xlsx,GeneTranscription_T47D_E2,miRNA_Isolation_FFPE,Targeted Drug Evaluation,SNP_Array,Unknown,1.5h,5_years,Passive,Coal_Dust,Hyperandrogenism,scRNA_seq_analysis,NR,Present,No_Ext,Yes,Not_Applicable,Brunneous,M2_Acute_Myeloblastic_Leukemia_With_Maturation,Pulmonary_cancer,tumor_sA_read1.fastq,82.5%,74.3%,ninety-two,ninety-three,Stage_III,'09,Patient_3_VHL_variant.vcf,2KB,Patient_Info.xlsx,Deceased_no_Remission,91-180D,Neuromotor_Alterations,SEQ34567Z8,6mo_followup,250bp,three_hundred_bp,200bp,52.1_SD,Unknown,Programmable freezing,U,NR,EGFR_upregulation,CARS1,RNA_Sequencing_Quant,Haplotype_Caller,G3,P5,15%,high_grade,U,3.5_cm,150500,36_hrs,Unknown,1.75m,U,G3,H2AZ1,Present,Pheochromocytoma_Paraganglioma,200_copies_ml,Prog_Est,None,Combined_PE,HPV-35,HPV-33,Micro_Parametrium,NR,Malignant_neoplasm_of_colon_unspecified,Malignant neoplasm of prostate,subject_root,Not_Available,Cerebral,2023-Mar-10,Hepatic_Metastasis,Not_Done,elevated,6.7,X-ray,Cyclophosphamide,Pending,0,Tx_Initiation,Persistent_Dx,55.8_kg,Poor_Prognosis,Metastatic,Illumina_27K,2023-Nov-20,71mm,Low_Risk,int_3,Group_3B,stage_3,Paraffin-Embedded,Active,3-4_Bridging_Fibrosis,20_very_poor,Successful,Serum_Creatinine,L3,micro,Local_recurrence,Mid,2017-05-30T09:55:00+00:00,2023-01-05T11:45Z,triple,Metastasis_Map,Illumina 20015964,KAPA Biosystems Stranded RNA-Seq,Qiagen N.V.,QIAseq UPX 3' Transcriptome Kit v1,Other,SS,Chromatin Interaction Analysis by Paired-End Tag Sequencing,two,quintuple,EGFR_7p11.2,7.3cm,Followed_Up,RND,Right_axillary,Epitrochlear,two,two,U,200x,v3,1_cm,NR,Perirenal_Fat,Spliced,Stage_2A,CGI_3250_Stable,V600E_BRAF,Ovarian,8f14e45fceea167a5a36dedd4bea2543_hash,100_fold_coverage,cm,NR,Present,Post-menopausal,Unk,no_met,Hepatic,Retrospective_Collection,M-Value Adjustment,moderately_high,Interspecies_Methylation_Comparison,Unknown,Positive,v3,NanoString_technology,hsa-miR-16,U,Minimal,high,1.8k,Flow_cytometric_analysis,miRNA_Variant,ALK rearrangement,Micropapillae,follicular_lymphoma,high,MSI-H,c.181C>A,III_Moderate,fifty,Normalized_Log_Ratio,dfci.harvard.edu,10%,Present,NA,NA,Not_available,No,U,Glucophage,Data_Not_Submitted,Familial cancer history,three_hundred,triple,ten,two_hundred,5_years,Lab Tech,Confirmed,Presence_of_Perineural_Invasion,Capsule_Intact,NR,U,On-Off_Oxygen_Therapy,one_and_half,seventy_five,2003,Type_1,Oral_fluid,Present,P3,likely_pathogenic,7a8b9c45-6748-d28e-2055-a8c2d38e79,tumor_at_surgical_margin_or_regional_lymph_nodes_with_distant_metastasis,Successful,Successful,Passed,Successful,SUCCESS,12.3%,23.5%,forty_five_percent,12.3%,7.2%,12.3%,12.3%,7.8%,87.0%,low,10%,23.4%,5.0%,23.5%,23.5%,U,>3,two,Malign,Pos,Melanoma_BRAF_Mutation,C3,PGM,Hyperdiploidy,PMID_27830973,4-5_servings,secundiparous,Live_Birth,U,U,150mg,Formalin_Fixed_Paraffin_Embedded,Metastatic carcinoma,Positive,G3,Mammary_Gland,not_specified,NR,DNA_analysis_bypassed,NR,Genetic Risk Assessment & Testing,NR,Bladder_dome,Local_Recurrence,Anti-Metastatic_Strategies,MEL-TRIAL-2023_ALT,Cancer_Immunotherapy,0.7%,92%,99%,15%,92%,10%,two,twenty_five,10%,CD274,NCT008605,B_AA,NA,Ukn,Illumina_EPIC,Mapped_Read_Cnt,MinION,100bp,Read2,Not_Reported,triple,71mm,Medical_Management,adjuvant_chemo,treatment_effects.pdf,fifties,NR,Biliary_Cancer,M_Great_Aunt,Yes,Smoker,unk,two,Y,2023-Mar-05,Yes,Unreleased,Not_Applicable,Microscopic_Residual,R2_macroscopic_residual,>20_mm,Present,v3,10%,Present,average,8.7,U,Overweight,Spatial_Gene_Expression,very_good,Tertiary_tumor,IM,genomic_variants.vcf,third,Treatment_Follow-up,metastatic,low,Present,NR,C-11 Choline,2.0,Ex8,H3F3B_H3.3B,miRNA_profiling,Grade_3,U,Colorectal,0,Y,Yes,0,Passed,Pass,Illumina Inc,2021-Nov-30,SLOAN KETTERING,3.8_cm,TP53_var,Transloc,Chromium_scATAC_seq_v1,Hypopharynx_aryepiglottic_fold,Pulmonary,triple,3.7_cm,31-50nm,Pap_stain_cervical_cancer,Cryostat_section,4:Data_Not_Collected,Strelka2,VarScan2,FACETS,Strelka2,V600E_BRAF,MSI_Testing,Qubit,2500 pM,PhiX.fasta,23.4%,H_and_E,moderate,Consent_retracted,Authorized,GRIDSS,EGFR_del19,Agilent G3 CGH+SNP,0.675,slight_loss,SRR2345678_unaligned.bam,CP9_PC,Frontal_lobe,U,PGDX_CancerSelect_203,5002-OncoTarget,Roche_NimbleGen_SeqCap_EZ_Exome_v3,Illumina,SeqCap_EZ_Exome_v3,Overexpressed,U/mL,0.1_ng/mL,10-19,CD70-targeted CAR-T Cells,U,>14_milligrams_per_liter,7_minutes,15_min,>60_min,End_Treat_Course_2,C03-10,Ciliary_body,Colorectal,0,Y1995,1995,5e5,five_k_one_two_zero,NM_000546,Positive,CSF,Prostatic,E4512_ALT,150mg,milliliters,8.5_weeks,NMD_No_Measurable_Disease,qod,Maintenance_Therapy,data_missing,4_months,Double-blind_Trial,Immune therapy,2.4_cm3,CNS_ependymoma,leukemia,U,0.8_mm,0.8_mm,Data_Restricted,Solitary,G4,Grade_3,Intermediate,Medium,7.1_cm,Central_zone,triploid,75%,2_Stable_Disease,Pedunculated,1.2_mm,1.2_cm,release_iteration,Not_Otherwise_Specified,Vape,Stage_1A3,T1c,Stage_1B,T1,III,Present,Present,1.5_years,NR,Surgical_Repair,NR,2023-03-22T17:45Z,twice,Not_specified,Del,Macrovascular_Invasion,HBV Genotype Analysis,Unreported,term_early,Atypical_mitotic_figures,low,C3,high_coverage,G3,Anaplastic,2023-09-05T16:15Z,https://github.com/precision-oncology/workflow_v3/commit/k1l2m3n4o5,2023-03-10T14:00Z,miRNA_Sequencing,v2.0.0,MCMX,Y2017,Y2007,Y3,2,PZ,Homozyg
2.00,EGFR_L858R,NA,SOLiD_Sequence_Adapter,Universal_adapter,C_diff_infection,Absent,Myasthenia,G4,60_years,adult,middle_aged,adult,N,EGFR_variants,CMI,M1b,N1c,Stage_IIA,T4,M1c,N1b_II,T1c_N0_M0,T2b,IV,three_days,heavy,Yearly,Yes,Never_Drinker,Miscellaneous,Normal_Sample1_Read2.fastq.gz,S4_89012,Quality_Score_Filtering,Hierarchical_Indexing_for_Spliced_Alignment_of_Transcripts,3000ul,200ul,Serum,0.4g,treatment_outcomes.xml,0.8ng/mL,NR,Ribonucleic_Acid,200ul,Cancer_Antigen_125,Localized,XO,Unknown,Weight_reduction,III,Unknown,Stage_4,E545K_PIK3CA,CD33_Sialic_Acid_Binding_Ig-like_Lectin_3,CCLE,Present,Grunerite,twenty-two point five,300bp,150bp,1,Present,ONT_Guppy,Guppy_v5.0.7,NA,B404,GH04,Non-CR_Non-PD,Caecum,R,Pen-Strep,Hb_min,blood_pH_max,obese_class_1,1.85_m2,Present,1.2_mm,NA,Clinical_Presentation,ILC,HCM1_1011,Insufficient_Clinical_Data,Chronic_Kidney_Failure,NR,Progression,seven_hundred_fifty,PWID,15K,Cancer_Prevention_Facilities,DFCI,FAM,Chloroethene,Yes,Not_Reported,RG004_PT_B_NRM,D04-15,Unknown,H3K4monomethylation,translocation_11_19_q23_p13.1,20q,long_arm,moderate_smoker,25mm,level_4,completed,Concurrent_primary,Curcuma longa,F,Monoclonal,Absent,IMMUN-23-04,III,NR,III,not_reported,Yes,Drash_Syndrome,Not_Reported,500uM,Full_Consent,Y,1.5%,3%,IVC,three,QC_CNV_csv,CNVnator_Version0.3,gain,SNP Microarray,Micronesia,FR,cycle_4,2023-04-10T11:00Z,2021-03-04 00:00:00,Carl June,55.4kg,7p22,Methylation_Patterns,Affymetrix_Chip_File,Digital Imaging and Communications in Medicine,G12C,Patient_Metadata,Metabolics_Data,24d,8_weeks,-20 years,5_days,1.5_months,three_days,DOD_120,1_month,1_month,4_months,week_2,negative_1_year,5_days,4_months,4_months,6_months,-4,day_7,3_weeks,12.9_weeks,1_week,PHS000427,Socioeconomic_Position,Informed_Consent_Documents,DPP-4_Inhibitor,No,Unknown,triple,PR-Partial Remission,Germ_Cell_Tumors,NA,SUPP-00456MC,sixty-five,scitranslmed.aaf6853,Absent,Negative,Cytokine,Moderate,Keratinizing_Dysplasia,3_Capable_of_only_Limited_Selfcare,Postgraduate_Degree,NR,Polyvinyl_Alcohol_Particles,Solexa_seq,IIA,U,U,M1b,Absent,Not_reported,23.5%,format_error,No_Dysplasia,Yes,Not_Hispanic_Latino,Imaging_Evidence,Physical_Exam,missing,segment4,exp_setup_details.txt,CellMigrationAssay_PC3_Ctrl,DNA_Received,Protein Analysis,DNA_Methylation_Array,Unknown,2h,10_years,Community,General_Dust,Chronic_Autoimmune_Gastritis,GSEA_analysis,Foc,Present,Micro_Ext,No,Unknown,Griseous,M3_Acute_Promyelocytic_Leukemia,Prostatic_neoplasms,tumor_sA_read2.fastq,70.1%,80.1%,one hundred three,sixty-seven,NR,'95,Lung_Cancer_RNA_seq.fastq,4KB,RNA_sequencing_data.csv,Non-Responder,>180D,NR,SEQ45678A9,9mo_followup,300bp,three_fifty_bp,250bp,60.5_SD,NA,Glass-like freezing,Yes,U,HER2_enhancement,CLTCL1,CNV_Detection,Deep_Variant,G4,P4,20%,very_high_grade,Present,2.1_cm,75300,48_hrs,Yes,1.58m,Positive_Response,Grade_X,H2AZ2,Absent,Pheochromocytoma_Paraganglioma,350_copies_ml,Unk,NR,Progesterone_mono,HPV-39,HPV-39,Not_Applicable,Radical_Hyst,Malignant_neoplasm_of_bladder_unspecified,Malignant neoplasm of sigmoid colon,individual_root,Unfavorable,Hepatic,2023-Apr-05,Pulmonary_Metastasis,NR,high,3.2,CT_scan,Methotrexate,Completed,1,Genomic_Seq_Start,Progressive_Dx,60.1_kg,Unknown,Metastatic_Special,Illumina_450K,2024-Jan-05,93mm,Low_Intermediate_Risk,int_4,Group_2A,stage_4,Non-FFPE,Inactive,5_Incomplete_Cirrhosis,30_severely_disabled,Not_Determined,Beta-hCG,L4,not_reported,Data_not_collected,NR,2018-01-19T16:33:45+00:00,2021-07-22T16:00Z,quadruple,Carcinoma_Cell_Library,Illumina 20018705,Takara SMARTer Stranded Total RNA-Seq,New England Biolabs Inc.,SMARTer Stranded Total RNA-Seq v2,Amplification,US,Ribonucleic Acid Sequencing,three,decuple,KRAS_12p12.1,10.1cm,NA,MRND,Not_Otherwise_Specified,Mediastinal,three,three,Present,400x,v4,1.5_cm,Negative,Kidney,Single,Stage_2B,CGI_4120_Methyl_Inc,E545K_PIK3CA,Pancreatic,c9f0f895fb98ab9159f51fd0297e236d_hash,150_fold_coverage,cm,Sonic_Hedgehog,NR,Pre-menopausal,Present,not_rptd,Pulmonary,Prospective_Collection,CpG Site Reannotation,low,Array_to_Sequence_Methylation_Liftover,Present,Unk,v4,miRNA_microarray,hsa-miR-34a,Yes,NR,very_high,1.25k,Immunocytochemistry,Missense_Variant,PD-L1 level,Discohesive,bronchioloalveolar_carcinoma,intermediate,MSS,c.37G>A,IV_Severe,seventy_two,Comparative_Log_Ratio,sanger.ac.uk,15.75%,Absent,Missing,NA,NA,Yes,Present,HMG-CoA_Reductase_Inhibitor,Data_Unknown,Partial treatment efficacy,four_hundred,quad,fifteen,three_hundred_fifty,8_years,Pharmacy Specialist,Denied,Status_of_Hormone_Receptors,Capsule_Ruptured,Positive,Yes,On-Off_Oxygen_Therapy,two,three_hundred,2005,Type_2,Bone_marrow_sample,Absent,P4,pathogenic,9d0e1f3b-1443-adbb-57c7-f29b6d2a1b,tumor_at_surgical_margin_or_regional_lymph_nodes_no_distant_metastasis,NA,NA,NA,NA,UNK,0.9%,34.9%,forty_seven_percent,15.0%,34.9%,15.0%,4.6%,10.3%,76.3%,moderate_low,15%,7.9%,7.8%,34.9%,34.1%,Present,NR,three,NR,Neg,Colon_KRAS_Mutation_Screen,D4,MinION,Hypodiploidy,PMID_28954789,6-7_servings,triparous,Pregnancy_Loss,Y,Yes,200mg,Unfixed,ESS,Negative,G4,Ocular,unknown,Unknown,sequencing_not_performed,NA,End-of-Life Care Services,Unknown,Biliary_bladder,Regional_Recurrence,Genomic_Analysis_of_Breast_Cancer,LUNG-CR-2022_ALT,Drug_Resistance,1%,76%,92%,20%,87%,15%,three,thirty,15%,BRCA1,NCT009340,NH_PI,Present,Present,Affymetrix_Tiling_2.0,Unmapped_Read_Cnt,RS_II,150bp,Read3,Patient_Refusal,quadruple,93mm,No_Intervention,neoadjuvant_chemo,genomic_variants.json,twenties,UNK,HHV8-associated_Sarcoma,M_Half_Sister,No,Smoker,present,three,N,2023-Apr-10,No,Available,Not_Applicable,Macroscopic_Residual,RX_cannot_be_assessed,No_macroscopic_disease,Absent,v4,15%,Absent,below_average,7.3,Present,Hereditary_cancer_syndrome,Targeted_Sequencing,good,Quaternary_tumor,SC,gene_expression.tsv,fourth,Circulating_Tumor_DNA,primary_blood_derived,moderate_low,Present,Positive,Prostate-Specific Membrane Antigen,2.1,Ex11,KCNJ5_GIRK4,DNA_methylation_analysis,Grade_4,Present,Prostatic,1,N,No,1,NA,Unknown,NCI,2022-Jan-20,JOHNS HOPKINS,0.9_cm,MLH1_var,Inv,SmartSeq2,Mandibular_gingiva,Osseous,quadruple,1.8_cm,51-100nm,Masson_trichrome_stained_liver_cancer,FFPE,5:Status_Unknown,GATK4_Mutect2,SomaticSniper,TITAN,GATK_Mutect2,L858R_EGFR,3C_Technique,BioSpectrometer_Kinetic,5000 pM,pUC.fasta,7.9%,H_and_E,strong,Low_data_quality,Revoked,LUMPYSV,KRAS_G12C_variant_identification,Illumina Omni2.5-8 Infinium,0.123,gain,SRR8765432_unaligned.bam,TT67_RD,NR,Yes,SeqCap_VCRome_v2.1,KitX9-BioPrime,Agilent_SureSelect_XT_All_Exon_V7,ThermoFisher,SureSelectXT2_Human_All_Exon_7,Increased,cells_per_mL,15.3_ng/mL,20-29,MAGE-A4-specific CD8alpha T Cells,Present,>14_milligrams_per_liter,10_minutes,20_min,not_reported,Follow_up,D04-15,Lip_external,Pancreatic,1,Y1965,2000,7.5e5,seven_hundred_sixty_eight,NM_005157,NA,Cardiac,Colorectal,EA5142_ALT,200mg,milligrams,13_weeks,NR_No_Response,qid,Primary_Therapy,treatment_given,6_months,Unknown_Therapy,Endocrine therapy,3.8_cm3,CNS_medulloblastoma,lymphoma,Y,6.7_mm,4.7_mm,NA,NA,Grade_B,Grade_4,Sparse,Low,3.3_cm,Anterior_fibromuscular_zone,tetraploid,65%,3_Progressive_Disease,Not_Specified,1.5_mm,3.7_cm,data_iteration,Industrial_smoke,Diverse,Stage_2A,T2b,Stage_1B1,T1a,IV,Present,NR,2_years,Rt,Natural_Resolution,R,2023-04-08T12:00Z,thrice,Not_specified,Delins,Microvascular_Invasion,Anti-HBs,Unknown,term_full,Clear_cell_content_>75%,moderately_low,D4,very_high_coverage,G4,NA,2023-10-10T11:00Z,https://github.com/bioinformatics-tools/workflow_v4/commit/p6q7r8s9t0,2023-04-05T16:30Z,CNV_Analysis,v2.5.3,MCMXIV,Y2018,Y2008,Y4,5,TZ,NR
2.05,PIK3CA_E545K,Warning,Ion_Adapter,Multiplexing_adapter,Diabetic_nephropathy,NR,Hearing Loss,G5,70_years,young_adult,senior,midlife,Yes,BRAF_variants,CMV_disease,M1c,N2,Stage_III,T4a,M2,N1b_III,T2a_N0_M0,T3a,V,four_days,very_heavy,Weekly,No,Data_Not_Provided,Unknown,Tumor_Sample2_Read1.fastq.gz,S5_45678,Read_Deduplication,Novocraft,4500ul,250ul,PBMCs,0.5g,survival_stats.h5,3.6ng/mL,Adjacent_to_Tumor,Unknown,250ul,Alpha-Fetoprotein,NR,XXX,Present,Additional_symptoms,IV,Yes,Stage_3,L858R_EGFR,CD45_Leukocyte_Common_Antigen,ICGC,U,Riebeckite,thirty-seven point nine,350bp,175bp,0,NR,IonTorrent_Suite,Albacore_v2.1.10,Warning,B505,IJ05,PPD-Pseudo_Progression,Diaphragma,Unk,L-Gln,Glu_min,platelet_count_upper,obese_class_2,1.95_m2,NR,1.5_mm,NR,Monitoring,TNBC,HCM1_1314,General_Issue,Infectious_Diseases,SSDI,Other,two_hundred_ninety,Missing_Data,20K,Pediatric_Oncology_Centers,MCCC,FAM,Aroclors,No,Unknown,RG005_PT_C_TMR,E05-20,Unknown,H3K4trimethylation,translocation_3_5_q25_q34,22q,long_arm,heavy_smoker,30mm,NR,available,Not_Specified,Camellia sinensis,N/A,Monoclonal,Present,THERA-23-05,IV,Unknown,IV,data_not_available,Not_Reported,Diabetic_Neuropathy,Not_Reported,750uM,Waiver,NR,2%,7%,Renal,four,read_counts_normalized_txt,Manta_StructuralVariant,loss,MLPA,Guatemala,DE,cycle_5,2023-05-25T08:30Z,2021-03-05 00:00:00,Mary-Claire King,82.3kg,9q34,Protein_Expression,Comma_Separated_Values,Neuroimaging Informatics Technology Initiative,Del19/L858R,CN_Levels_By_Gene,DNA_Methylation_Data,31d,10_weeks,-40 years,1_week,2_months,five_days,DOD_150,1.5_months,1.5_months,6_months,week_3,negative_6_months,1_week,5_months,5_months,7_months,-5,day_14,4_weeks,17.1_weeks,2_weeks,PHS000428,Residence_Area,Magnetic_Resonance_Imaging,NR,Y,Yes,quadruple,PSR-Pseudoprogression,Giant_Cell_Neoplasms,Remote_>2cm,SUPP-00567PC,one hundred three,s1470-2045(19)30150-5,Present,NR,Cytokine,Absent,Nonkeratinizing_Dysplasia,4_Completely_Disabled,Secondary_Education_Incomplete,Not_Specified,Embolic_Coils,Illumina_v1.3,IIB,M0,E2,M1c,Absent,Present,29.0%,checksum_failure,Not_Reported,No,Not_Reported,Imaging_Evidence,Biomarker_Positivity,5+_days,segment5,gene_expr_analysis_methods.csv,CellInvasionAssay_A549_TGFb,Whole_Genome_Amplification,Metabolic Profiling,RPPA,Not_Reported,2.5h,15_years,Not_specified,Cannabis,Familial_Ovarian_Cancer,Path_analysis,Ext,Not_Assessed,Micro_Ext,Positive,T4b_Very_Advanced,Virid,M4_Acute_Myelomonocytic_Leukemia,Ovarian_neoplasms,norm_sB_read1.fastq,88.4%,66.7%,sixty-seven,fifty-eight,Unk,'95,KRAS_Mutation_Expression.xlsx,8KB,Exome_sequence_data.vcf,Missing,0-30D,Convulsions,SEQ56789B0,1yr_followup,350bp,four_hundred_bp,300bp,42.3_SD,NA,Instantaneous freezing,Yes,UNSPEC,KRAS_high_mutation_load,ISX,DNA_Methylation_Processing,Strelka_2,G5,P4,25%,low_grade,NR,4.7_cm,30000,60_hrs,Unknown,1.68m,No_Response,NR,H2AZv2,Absent,LGG,500_copies_ml,Unk,Unk,Unknown,HPV-45,HPV-45,Not_Documented,Simple_Hyst,Malignant_neoplasm_of_prostate,Malignant neoplasm of bladder unspecified,subject_root,Data_Missing,Colorectal,2023-May-25,No_Abnormality_Detected,Pos,very_high,5.5,MRI,Not_Reported,0,No,Dx_Recurrence,Recurrent_Dx,25.4_kg,Unknown,NR,Illumina_Epic,2024-Mar-10,120mm,Low_Risk,int_5,Group_2B,NR,Paraffin-Embedded,0,6_Full_Cirrhosis,40_disabled,Warning,HPV,L5,unknown,No_evidence_of_disease,R,2019-11-08T11:04:20+00:00,2022-09-12T10:20Z,quintuple,Angiogenesis_Genes,Qiagen 180493,Qiagen QIAseq Stranded mRNA,Roche Holding AG,NEBNext Ultra II RNA Library Prep v3,Oligo-dT_Selection,US,Precision Medicine Sequencing,four,pentadecuple,APC_5q22.2,12.6cm,Followed_Up,RND,Left_axillary,Common_iliac,four,four,U,600x,v5,2_cm,Unknown,Kidney_Capsule,Apart,Stage_4A,CGI_5287_Methyl_Dec,T167A_PTEN,Parotid,45c48cce2e2d7fbdea1afc51c7c6ad26_hash,200_fold_coverage,cm,U,Absent,Unknown,Absent,regional_met,Nodal,Prospective_Collection,Batch Effects Removal,moderately_low,ENCODE_Methylation_Conversion,Unknown,Positive,v5,ISH,hsa-miR-15a,Yes,NA,very_high,2k,Chromosome_analysis,Nonsense_Mediated_Decay_Variant,KRAS gene mutation analysis,PRCC_pattern,adenoma_benign,high,MSS,c.37G>A,V_Intensive,eighty_eight,coding_sequence,genome.wustl.edu,22.5%,Absent,Absent,NA,Present,Yes,U,Not_Otherwise_Specified,Present,Tumor-specific genetic alteration,five_hundred,quint,twenty,four_hundred_fifty,10_years,Biomedical Researcher,Embedded,Status_of_HER2,Unknown,Unknown,No,Continuous_Oxygen_Therapy,five,one_eighty,2007,Type_1,Pleural_effusion_fluid,Absent,P5,variant_of_uncertain_significance,b3d1126f-b74f-939c-5a3b-5b76f2c491,tumor_penetrates_renal_capsule_or_involves_renal_sinus_negative_margins_and_lymph_nodes_with_distant_metastasis,Warning,Warning,Warning,Warning,WARNING,15.4%,45.0%,fifty_percent,20.5%,45.3%,18.2%,9.1%,12.1%,82.1%,moderate,20%,33.1%,10.4%,40.0%,45.0%,Absent,UNK,four,Unk,Pos,Glioblastoma_IDH1_Mutation_Test,E5,NovaSeq,Near-diploidy,PMID_29567829,8-9_servings,quadriparous,NR,No,Yes,250mg,Cryogenically_Frozen,GBM,Negative,G5,Oral_Cavity,present,Yes,DNA_analysis_bypassed,Colorectal_Screening,Childhood Cancer Research Initiatives,Yes,Renal_NOS,NR,Lung_Cancer_Research_Projects,BRCA-SEQ-21_ALT,Radiotherapy,1.2%,89%,96%,25%,93%,20%,four,thirty_five,20%,BRCA2,ALL0031,NA,Present,Ukn,Agilent_CpG_Island,Properly_Paired_Read_Cnt,NovaSeq_6000,200bp,NA,Schedule_Issues,quintuple,120mm,NA,palliative_chemo,clinical_study_findings.docx,sixties,UNSPEC,Myeloid_Leukemia,Biological_Sister,NR,Non-smoker,unk,four,1,2023-May-25,Y,Not_Available,Enabled,Not_Assessed,R2_macroscopic_residual,>20_mm,Not_reported,v5,20%,Absent,low,6.5,U,Carcinogenic_exposure,Long_read_Sequencing,above_average,Metastasis,Top,gene_fusions.txt,fifth,Healthy_Bone_Marrow,normal_tissue,moderate,Present,Unknown,F-18 NaF,3.0.5,Ex14,KDM6A_UTX,Epigenetic_modification_study,Grade_5,NR,Pancreatic,0,Positive,1,0,Warning,Warning,MDACC,2022-Apr-05,UCLA HEALTH,4.4_cm,MSH2_var,Ins,SmartSeq2,Lower_extremity,Cerebral,quintuple,5.2_cm,101-150nm,Giemsa_stained_leukemia_cells,Terminal_deoxynucleotidyl_transferase_dUTP_nick_end_labeling,6:Not_Reported,SomaticSniper,GATK_Mutect2,CNV_kit,SomaticSniper,E545K_PIK3CA,TMB_Testing,Microvolume_Protein_Quantitation,10000 pM,Lambda.fasta,34.1%,IHC,very_strong,Lost_sample,Revoked,SvABASV,ALK_translocation_analysis,Affymetrix CytoScan Array,0.908,loss,SRR3456789_unaligned.bam,CQ33_SE,Occipital_lobe,No,SureSelect_CGCI_BLGSP_4.6Mb,CM300-CaptureMax,ThermoFisher_Ion_AmpliSeq_Exome,IDT,Nextera_Rapid_Capture_Exome_v1.2,Elevated,g/L,4.6_ng/mL,30-39,Nectin-4/FAP CAR-T Cells,Present,>14_mg_per_L,12_minutes,25_min,<=5_min,Not_Reported,E05-20,Gall_bladder,Prostatic,No,Y2001,2005,1e6,fifteen_k,ENST00000269305,NR,Mandibular,Cerebral,A081105_ALT,250mg,milligrams_per_deciliter,17_weeks,NTM_Normalization_of_Tumor_Markers,qid,Preparatory_Therapy,no_treatment,7_months,Intracavitary_Radiotherapy,Molecularly targeted therapy,5.0_cm3,CNS_other,melanoma,NR,2.4_mm,2.1_mm,NR,NA,Grade_X,Grade_4,Sparse,High,5.6_cm,Periurethral_zone,pentaploid,55%,NR,Convex,2.0_mm,6.0_cm,version_release,Cannabis_smoke,Water_Pipe,Stage_2C1,T2c,Stage_2A1,T1a1,V,Absent,NR,2.5_years,Bilat,Orchidectomy,NR,2023-05-19T08:30Z,four_times,Not_specified,Ins,Absent,HCV Genotype Analysis,LTFU,term_late,Anomalous_nuclei,moderate,E5,NA,Grade_Unassigned,NR,2023-11-02T18:30Z,https://github.com/clinical-genomics/workflow_v5/commit/u1v2w3x4y5,2023-05-25T11:15Z,GISTIC2_Focal_Deletion,v3.0.0,MCMXVIII,Y2019,Y2009,Y5,10,UZ,Nullizyg
2.10,TP53_R175H,Warning,P5_Index_Adapter,Sequencing_adapter,High_grade_dysplasia,NR,Tubal Hemorrhage,G1,50_years,thirties,elderly,mature_adult,No,PIK3CA_variants,HIV_related_encephalopathy,MX,N2c,Stage_IIIA,T4b,MX,N1b_IV,T2b_N0_M0,T3b,VI,five_days,light,Weekly,No,Infrequent_Drinker,Vinous_Alcohol,Tumor_Sample2_Read2.fastq.gz,S6_90123,Adapter_Trimming,Genome_Analysis_Toolkit,1000ul,300ul,Bone_marrow,0.6g,RNA_sequencing_counts.tsv,5.1ng/mL,Neoplastic,Messenger_RNA,300ul,Carcinoembryonic_Antigen,Positive,Klinefelter_syndrome,NR,Diaphoresis_nocturnal,U,Unknown,Stage_3,T102*_PTEN,CD5_T-Cell_Surface_Glycoprotein_CD5,SRA,Present,Riebeckite,twenty-five point three,400bp,200bp,No,NR,PacBio_SMRTAnalysis,Bonito_v0.4.0,Successful,B606,KL06,PR-Part_Response,Gaster Fundus,R,HEPES,Ca_min,serum_cholesterol_high,obese_class_3,2.06_m2,Present,2.0_mm,Sporadic_BL_adult,Early_Detection,HER2_pos_breast_cancer,HCM1_1617,Prior_Treatment_Issue,Non-Neoplastic_Causes,Unk,Subject_Withdrawal,six_hundred_ten,Not_Specified,25K,Community_Oncology_Centers,CCTCI,FAM,Arsenous acid,U,B,RG006_PT_C_NRM,F06-25,Unknown,H3K9trimethylation,translocation_6_11_q27_q23,Xq,long_arm,very_heavy_smoker,35mm,level_5,under_evaluation,Secondary,Selenomethionine,T,Monoclonal,Present,DIAGN-23-06,U,High_Risk,U,not_reported,No,Cardiovascular_Disease,Not_Reported,1mM,Waiver,NR,2.5%,15%,Hepatic,five,genotyping_results_CNV_json,CrossMap_ConversionTool,loss,qPCR,Israel,GU,cycle_6,2023-06-30T13:20Z,2021-03-06 00:00:00,Siddhartha Mukherjee,76.8kg,11p15,Seq_Data,JP2,Comma-Separated Values,EML4-ALK,Transcript_Expression_Quantification,Patient_Clinical_Data,45d,12_weeks,-8 years,1.5_weeks,3_months,one_week,DOD_180,2_months,2_months,7_months,week_5,negative_3_months,10_days,6_months,6_months,9_months,-6,day_21,5_weeks,21.4_weeks,3_weeks,PHS000429,Relationship_Status,Computed_Tomography_Scans,Oral_Antidiabetic_Agent,N,No,quintuple,RD-Responsive,Leukemia_Unspecified,NA,SUPP-00678GB,eighty-eight,nejmoa1809615,Absent,NR,Cytokine,Not_Reported,NR,5_Dead,Some_Postsecondary_Education,NR,Microspheres,Illumina_v1.7,III,M0,E2,M2,Present,Present,34.4%,checksum_failure,Unknown,No,Not_Collected,Imaging_Evidence,Biopsy_Histologic_Confirmation,3-4_days,segment6,seq_method_details.pdf,ChemoSensitivity_GBM8401_TMZ,Whole_Genome_Amplification_X,RNA-Seq,RNA-seq,Not_Reported,3h,20_years,Not_specified,Ionizing_Radiation,Neurocysticercosis,Microarray_analysis,NR,Not_Assessed,Gross_Ext,Negative,T3_Minimal,Corylus,M5_Acute_Monoblastic_and_Monocytic_Leukemia,Cutaneous_melanoma,norm_sB_read2.fastq,64.3%,82.4%,one hundred ten,one hundred ten,Stage_I,'95,Melanoma_Sample_Panel.ppt,16KB,Patient_Clinical_Notes.pdf,NR,0-30D,Neurosensory_Alterations,SEQ67890C1,18mo_followup,400bp,four_fifty_bp,350bp,38.7_SD,NA,Step-down freezing,Yes,F,PTEN_deletion,MYB,ChIP_Seq_Peak_Identification,Var_Scan2,NR,P4,30%,low_grade,Absent,5.3_cm,110400,72_hrs,Unknown,1.83m,U,Unknown,H31,NR,Pheochromocytoma_Paraganglioma,750_copies_ml,Unk,None,Progesterone_mono,HPV-51,HPV-51,Unknown_Status,Unknown,Malignant_neoplasm_of_pancreas_unspecified,Malignant neoplasm of pancreas unspecified,subject_root,Unfavorable,Pancreatic,2023-Jun-30,Data_Not_Available,Unknown,minimal,7.8,X-ray,Other,0,No,Sample_Collection,Refractory_Dx,35.7_kg,Unknown,Unknown,Ion_PGM,2024-May-30,154mm,High_Intermediate_Risk,int_6,Group_2C,UNK,Paraffin-Embedded,1,Not_Reported,50_requires_considerable_assistance,Failure,Immature_Myelocytes,L6,unknown,Unknown_status,Uni,2020-02-29T18:15:55+00:00,2023-02-28T08:30Z,sextuple,Immune_Editing_DB,Takara 634413,Illumina Nextera XT DNA,Agilent,KAPA Hyper Prep Kit v5.4,Unspecified,FS,Whole Genome Sequencing,five,icosi,MYC_8q24.21,15.0cm,Not_Followed_Up,RND,Left_axillary,Unspecified,five,five,Absent,800x,v6,2.5_cm,Negative,Renal_Hilum,Bereaved,Stage_4B,CGI_6392_Stable,L858R_EGFR,Periorbital,d3d9446802a44259755d38e6d163e820_hash,250_fold_coverage,cm,Wingless_Pathway,NR,NR,Unk,unknown,Local,Prospective_Collection,Methylation Differential Analysis,very_high,Infinium_Array_Liftover,Unknown,NR,v6,Northern_analysis,hsa-miR-146a,Yes,NR,high,0.95k,DNA_microarray,Non_coding_Exon_Variant,HER2 amplification,Papillary_pattern,fibroadenoma_nos,intermediate,MSI-H,c.181C>A,IV_Severe,one_hundred_five,human_genome_version_19,cam.ac.uk,30%,Absent,Missing,Present,Not_available,Yes,NR,Glucophage,Collection_Prohibited,Recurrence likelihood high,six_hundred,sext,twenty_five,six_hundred,12_years,Public Health Expert,Not_Embedded,Proliferation_Index_Ki67,Capsule_Ruptured,Indeterminate,U,On-Demand_Oxygen_Therapy,ten,six_hundred,2009,Type_II,Peritoneal_fluid,Absent,P6,variant_of_uncertain_significance,c2e5de0a-8e4f-77a6-583c-5d8b3c5b7f,tumor_penetrates_renal_capsule_or_involves_renal_sinus_negative_margins_and_lymph_nodes_no_distant_metastasis,Failure,Warning,NA,NA,NR,9.7%,56.3%,fifty_two_percent,25.7%,9.1%,21.4%,15.4%,15.4%,69.4%,moderate_high,25%,18.5%,15.2%,45.6%,56.3%,U,1_to_3,five,Inadequate,NR,Leukemia_Flt3_Mutation_Analysis,F6,SureSelect,NR,PMID_30541042,10-11_servings,quintiparous,Miscarriage,NR,Yes,300mg,Collection_Prohibited,Nevus,Negative,G3,NA,not_specified,Data_Not_Collected,sequencing_not_performed,Colorectal_Screening,Mammography and Breast Health Education,No,Stomach_lesser_curvature_NOS,Regional_Metastasis,Melanoma_Genomics_Study,PANCR-PROJ-20_ALT,Cancer_Spread,1.5%,81%,94%,30%,88%,25%,five,forty,25%,PIK3CA,ALL03B1,NR,NR,Present,NimbleGen_720K,Duplicate_Read_Cnt,MiSeq,250bp,NA,Unknown,sextuple,154mm,Data_Not_Provided,maintenance_chemo,medical_imaging.dicom,seventies,UNK,Hepatocellular_Carcinoma,Nephew,NR,Smoker,unk,five,0,2023-Jun-30,N,Not_Available,Not_Applicable,Unknown,R2_macroscopic_residual,<10_mm,Absent,v6,25%,Absent,high,5.8,U,Persistent_inflammation,RiboSeq,average,Basal_cell,Inhal,dna_methylation.csv,sixth,Healthy_Lymphoid,normal_blood,moderate_high,Absent,Uncertain,F-18 NaF,3.1.2,Ex17,LYL1_LYLF,scRNA-seq,Grade_4,U,Hepatic,Yes,Negative,0,0,NA,Failure,Mayo Genomics Core,2022-Jun-18,UCSF HEALTH,1.7_cm,APC_var,CNV,Chromium_3p_GEX_v2,Not_Otherwise_Specified,Suprarenal_glands,sextuple,6.0_cm,151-200nm,PAS_stained_colorectal_cancer,Pap_stain,7:Never_Smoked,LoFreq,LoFreq,VarScan_2,LoFreq,T102*_PTEN,cfDNA_Analysis,Coomassie_Blue_Assay,20000 pM,MS2.fasta,45.5%,H_and_E,very_strong,Labeling_error,Authorized,BreakDancerSV,HER2_gene_amplification,Illumina HumanHap 550,0.457,normal,SRR9876543_unaligned.bam,GM21_TF,Parietal_lobe,Yes,SureSelect_Exon_v1.1_3Boosters,CTK420-SeqPure,Illumina_Nextera_Exome,Qiagen,Twist_Core_Exome,Moderate,g/dL,9.9_ng/mL,40-49,CDK4/6 Inhibitor BPI-16350,Absent,above_14_mg/L,15_minutes,30_min,31-60_min,Other,F06-25,Respiratory_system_ill_defined,Ovarian,1,Y1988,2010,1.25e6,twenty_three_k_four_five_six,NM_004333,NR,Occipital_Lymph_Nodes,Hepatic,E4512_ALT,300mg,milligrams_per_day,21_weeks,PD_Persistent_Disease,qw,Not_Applicable,no_treatment,8_months,External_Beam_Radiation_Low_Dose,Surgical removal,6.3_cm3,ALCL,glioma,NR,4.9_mm,5.3_mm,Pre-cancerous,NA,High,Grade_4,Abundant,High,8.9_cm,Apical_zone,hexaploid,45%,Unknown,Convex,2.4_mm,0.9_cm,dataset_release,Petroleum_smoke,Snuff,Stage_3A,T3a,Stage_3A1,T1c2,VI,Present,NR,3_years,Bilat,Natural_Resolution,Bilat,2023-06-30T16:20Z,five_times,Acquired_variant,Inv,NR,HBsAg,LTFU,postterm,Diffuse_growth_pattern,moderately_high,F6,unknown,NR,Anaplastic,2023-12-20T07:45Z,https://github.com/cancer-analysis/workflow_v6/commit/z6a7b8c9d0,2023-06-30T13:45Z,Gene_Expression_Counts,v3.1.4,MCMXXII,Y2020,Y2010,Y6,15,TZ,Unk
1.80,TP53_Y220C,Warning,P7_Index_Adapter,Library_adapter,Glandular_hyperplasia,Present,Papilledema,G4,80_years,early_forties,adolescent,late_adult,N,PTEN_variants,Cystoisosporiasis,Data_Not_Collected,N2_microinvasion,Stage_IIIC,Ta,NA,N1c,T3_N0_M0,T4a,VII,six_days,light,Daily,NR,Casual_Drinker,Spirits,Normal_Sample2_Read1.fastq.gz,S7_56789,Complexity_Filtering,Top_Hat2,2500ul,350ul,Urine,0.7g,epigenetic_dna_methylation_profiles.parquet,0.5ng/mL,Not_Determined,MicroRNA,350ul,ERBB2,Fibrosis,Triple_X,NR,Pyrexia,IV,Unknown,Stage_2,R876*_APC,CD56_NCAM,EGA,Absent,Riebeckite,forty point one,450bp,225bp,0,Present,bcftools,Guppy_v3.2.10,Successful,B707,MN07,PSR-Pseudo_Response,Humeri,Unk,NaPyruvate,WBC_min,creatinine_serum_upper,overweight,2.17_m2,NR,2.3_mm,Sporadic_BL_pediatric,Monitoring,Follicular_lymphoma,HCM1_1920,Incorrect_Shipment,Data_Not_Available,Postmortem_Examination,AE,four_hundred,Blood_Product_Recipient,30K,NCI_Designated_Centers,FHCRC,FAM,Chromium(VI),U,Unknown,RG007_PT_D_TMR,G07-30,H3K27ac_antibody_ab4729,Control,translocation_6_9,3q,NR,moderate_smoker,40mm,level_4,received,Unreported,Ascorbic Acid,N/A,Monoclonal,Present,PREVE-23-07,I,High_Risk,I,not_reported,No,Lymphomatoid_Papulosis,Not_Reported,1.5mM,Waiver,NR,3%,1%,NR,six,CNV_ratios_tsv,LiftOver_with_minimap2,loss,dPCR,Malaysia,GT,cycle_7,2023-07-15T17:05Z,2021-03-07 00:00:00,Emmanuelle Charpentier,63.7kg,13q14,Raw_Seq_Reads,JavaScript_Object_Notation,Tab-Separated Values,BRCA1+,Germline_Variants,Radiology_Data,60d,14_weeks,-14 years,2_weeks,4_months,ten_days,DOD_210,3_months,3_months,8_months,week_6,negative_1_month,2_weeks,7_months,7_months,12_months,-7,day_28,6_weeks,30_weeks,4_weeks,PHS000430,Educational_Attainment,Positron_Emission_Tomography_Scans,Antidiabetic,1,Data_Not_Collected,sextuple,RP-Response Achieved,Lipoma_Related_Tumors,Remote_>2cm,SUPP-00789SC,seventy-four,jncidjx250,Absent,Negative,Cytokine,Severe,Other_Dysplasia,Not_Assessed,Secondary_Education_Incomplete,NR,Yttrium-90_Sirspheres,Phred33,Unknown,U,NR,MX,NR,Absent,41.8%,checksum_failure,Unknown,NR,Hispanic_Latino,Imaging_Evidence,Biopsy_Histologic_Confirmation,5+_days,segment7,medication_schedule.docx,EndothelialGrowth_HUVEC_VEGF,Total_RNA_Extraction,ChIP-Seq,Validation_Experiment,Unknown,4h,25_years,Not_specified,Radon_Gas,RA,Prot_expr_profiling,Ext,Not_Assessed,Micro_Ext,Yes,T3_Minimal,NR,M6_Acute_Erythroid_Leukemia,Pancreatic_neoplasms,patientX_preRx_read1.fastq,79.8%,78.8%,fifty-eight,ninety-nine,Stage_III,'88,Glioblastoma_Patient5_CopyNumberVariation.csv,32KB,Lab_Test_Results.json,Adverse_Event,0-30D,Unknown,SEQ78901D2,2yr_followup,450bp,five_hundred_bp,400bp,45.9_SD,NA,Immersion freezing,Yes,UNSPEC,BCL2_elevated_expression,RECQL4,miRNA_Analysis,Free_Bayes,G2,P4,35%,low_grade,Present,6.0_cm,95700,84_hrs,Yes,1.45m,No_Response,G2,H32,Absent,LGG,1000_copies_ml,Unk,Past,NR,HPV-53,HPV-52,Vaginal_Margin,Hysterectomy_SPEC,Malignant_neoplasm_of_stomach_unspecified,Malignant neoplasm of stomach unspecified,pt_root,Data_Missing,Prostatic,2023-Jul-15,Lymphadenopathy,Neg,below_average,9.0,Ultrasound,Unknown,0,1,Enrollment_Date,Residual_Dx,40.3_kg,Unknown,Metastatic_Special,454_Sequencing,2024-Aug-15,186mm,Low_Risk,int_7,Group_4,stage_3,Paraffin-Embedded,Inactive,Unknown,70_cares_for_self,Not_Available,Myeloblasts,L7,micro,Present_with_tumor,NA,2021-04-14T07:46:10+00:00,2021-04-18T12:05Z,septuple,Cancer_Stem_Cell_Network,Illumina 20020594,Illumina TruSeq DNA PCR-Free,Takara Bio Inc.,SureSelectXT Human All Exon Kit v7,MicroRNA_Length_Selection,NA,Whole Exome Sequencing,six,icosipent,CDKN2A_9p21.3,17.8cm,Followed_Up,MRND,Not_Otherwise_Specified,External_iliac,six,six,Absent,1000x,v7,3_cm,Positive,Renal_Vein,Dissolved,Stage_4A,CGI_7450_Methyl_Inc,R876*_APC,Pericardial,6512bd43d9caa6e02c990b0a82652dca_hash,300_fold_coverage,cm,ND,Absent,Post-menopausal,Unk,unknown,Pleural,Prospective_Collection,Technical Replicates Management,very_low,Reduced_Representation_Bisulfite_Sequencing_to_GRCh38,NR,Unk,v7,ddPCR,hsa-miR-10b,NR,NR,moderate,1.7k,STR_analysis,Splice_Site_Variant,PIK3CA gene analysis,NOS,ductal_carcinoma_nos,intermediate,MSS,c.37G>A,I_Minimal,one_hundred_twenty_three,splicing_junctions,vumc.org,37.2%,Present,Missing,NA,Absent,No,U,Glucophage,Data_Unknown,Experimental therapy participation,seven_hundred,oct,thirty,seven_hundred_fifty,15_years,Bioengineer,Compound_Used,Presence_of_Tumor_Infiltrating_Lymphocytes,Not_Reported,Indeterminate,No,On-Off_Oxygen_Therapy,fifteen,ninety,2011,Type_1,CSF,NR,P7,variant_of_uncertain_significance,d8f5e21e-4c4a-af9f-8c7a-9e5985b8f0,not_reported,Warning,Successful,Warning,NA,SUCCESS,3.2%,67.1%,fifty_five_percent,30.1%,15.4%,25.7%,3.2%,18.6%,55.8%,high,30%,9.7%,20.0%,51.3%,67.8%,NR,NR,six,Atyp,NR,Pancreatic_CDKN2A_Analysis,G7,Chromium,Tetraploidy,PMID_31298756,12-13_servings,sextiparous,Still_Birth,U,NR,350mg,Not_Disclosed,blue,No,G1,Female_Genital_Tract_NOS,Data_Not_Collected,Unknown,DNA_sequencing_omitted,NA,Thoracic Oncology Studies,Unknown,Cervical_lymph_nodes,Unknown,Early_Detection_of_Pancreatic_Cancer,GLIO-GS-19_ALT,Neoangiogenesis,1.8%,98%,97%,35%,90%,30%,six,forty_five,30%,PTEN,AML0631,Other,NR,NR,CGH_Microarray,Avg_Read_Length,S5,300bp,Read3,Physician_Decision,septuple,182mm,PPI_Therapy,endocrine_therapy,histopathology_reports.zip,twenties,NR,Hodgkin_and_Non-Hodgkin_Lymphoma,Sibling,No,Non-smoker,unk,six,Yes,2023-Jul-15,1,Not_Published,Enabled,Not_Assessed,R1_microscopic_residual,10-20_mm,Not_reported,v7,30%,Absent,below_average,4.9,NR,Elderly,miRNA_Sequencing,slightly_below_average,Squamous_cell,IP,cnv_data.bed,seventh,Uncertain_Neoplasms,cell_lines,high,Present,Positive,F-18 NaF,4.0,Ex20,PHF6_PHF6,Protein_phosphorylation_analysis,Grade_4,Absent,Gastric,No,1,Yes,Yes,NA,Unknown,MSKCC,2022-Sep-09,MASS GENERAL,2.9_cm,PTEN_var,Tandem_dup,Chromium_3p_GEX_v2,Larynx_supraglottic,Peritoneal,septuple,0.9_cm,201-250nm,Oil_Red_O_stained_liposarcoma,May-Grunwald-Giemsa_stain,5:Status_Unknown,Platypus_variant_caller,SiNVICT,CopywriteR,Pindel,R876*_APC,PTT,Bicinchoninic_Acid_Assay,50000 pM,VirusMix.fasta,16.7%,H_and_E,strong,Equipment_failure,Authorized,VarScan2SV,PIK3CA_mutational_spectrum,Thermo Fisher OncoScan CNV,0.289,gain,SRR4567890_unaligned.bam,MC55_PG,Spinal_cord,No,Twist_Broad_PanCancer_396,TF500-TargetFlex,Twist_Bioscience_Core_Exome,OGT,AmpliSeq_Exome_v5,Within Normal Limits,mg_per_24hr,1.2_ng/mL,51-75,Cetuximab,U,>14_mg_per_L,18_minutes,35_min,6-30_min,Post_Horm_Therapy,G07-30,NR,Hepatic,1,Y1975,2012,1.5e6,four_k_ninety_six,NM_002524,Positive,Ungual,Pancreatic,A081801_ALT,350mg,milligrams_per_kilogram,30_weeks,TO_Treatment_Ongoing,qw_for_1yr,Prophylaxis,no_treatment,9_months,Radioiodine_Therapy,Hematopoietic stem cell transplantation,7.1_cm3,RT_kidney,neuroblastoma,NR,8.3_mm,6.0_mm,Initial,NR,Intermediate,Not_Reported,Sparse,Medium,1.2_cm,Basal_zone,heptaploid,35%,2_Stable_Disease,Convex,2.8_mm,5.4_cm,publication_iteration,Cigarette_smoke,Cigarillo,Stage_3B,T3d,Stage_3C2,T2b,VII,NR,Present,3.5_years,Bilat,Surgical_Repair,Bilat,2023-07-14T10:10Z,six_times,Not_specified,Loss_of_Function,Unknown,Anti-HCV,Unknown,preterm_early,Tissue_necrosis,high,G7,NA,Unknown,NR,2024-01-15T13:30Z,https://github.com/molecular-diagnostics/workflow_v7/commit/e1f2g3h4i5,2023-07-22T10:00Z,Structural_Variant_Aggregation,v4.0.0,MCMXXVI,Y2021,Y2011,Y7,20,PZ,Homozyg
1.75,KIT_D816V,Warning,MiSeq_Sequence_Adapter,PCR_adapter,CIS_with_keratinizing_dysplasia,Absent,Alopecia,G4,18_years,late_forties,adolescent,early_senior,No,CDKN2A_variants,M_avium_complex,Not_Reported,N3,Stage_IV,DCIS_Tis,NR,N2b,T3a_N0_M0,T4b,VIII,seven_days,none,Monthly,U,Not_Known,Spirits,Normal_Sample2_Read2.fastq.gz,S8_01234,Chimera_Detection,Short_Oligonucleotide_Analysis_Package,750ul,400ul,Saliva,0.8g,proteomics_data.dat,2.0ng/mL,ND,Protein,400ul,Programmed_Death-Ligand_1,NA,XO,NR,Additional_symptoms,NR,Yes,Stage_3,E1202K_ALK,CD7_T-Cell_Antigen,dbGaP,U,Riebeckite,thirty-two point six,500bp,250bp,0,Present,Freebayes,Albacore_v1.2.1,Successful,B808,OP08,RD-Resp_Disease,Nodi Lymphoidei Supraclaviculares,Unk,NEAA,Hct_min,bilirubin_total_max,obese_class_1,2.28_m2,Present,2.5_mm,Unknown_BL_adult,Monitoring,Hodgkins_lymphoma,HCM1_2223,Incorrect_Normal_Tissue_Origin,Kidney_Diseases,Vital_Records,AE,two_hundred_thirty,Data_Unavailable,35K,Integrated_Oncology_Centers,UCSF HDFCCC,FAM,Niccolous,No,Not_Reported,RG008_PT_D_NRM,H08-35,H3K27ac_antibody_ab4729,NA,translocation_8_21,4q,short_arm,heavy_smoker,45mm,level_2,stored,Different_type,Ubiquinone,N/A,Monoclonal,Absent,MOLEC-23-08,II,Intermediate_Risk,IV,data_not_available,No,Peutz-Jeghers_Syndrome,Not_Reported,2mM,Death_Related,N,3.5%,4%,Small_Intestine,seven,CNV_parameters_yaml,DELLY2_StructuralVariantLiftover,loss,Structural Variant Analysis,Serbia,JE,cycle_8,2023-08-20T10:10Z,2021-03-08 00:00:00,Jennifer Doudna,89.0kg,15q11,SNV,Sequence_Read_Archive_Extensible_Markup_Language,Hierarchical Data Format version 5,BRCA2+,RNA_Splice_Junctions,Histology_Data,75d,16_weeks,-48 years,3_weeks,5_months,two_weeks,DOD_240,4_months,4_months,9_months,month_2,negative_2_weeks,3_weeks,8_months,8_months,13_months,-8,day_35,8_weeks,34.3_weeks,5_weeks,PHS000431,Work_Status,Hematology_Results,SGLT2_Inhibitor,No,NR,septuple,TE-Early Evaluation,Mature_B_Cell_Lymphomas,NA,SUPP-00890OC,one hundred ten,cncr30888,Absent,Negative,Cytokine,Unknown,Unknown_Dysplasia,Data_Missing,Postgraduate_Degree,Intermediate_Risk,Yttrium-90_Theraspheres,Phred64,IA,M0,U,NR,NR,Absent,45.3%,checksum_failure,Low_Grade_Dysplasia,No,Unknown,Pathological_Confirmation,Imaging_Evidence,missing,segment8,tissue_analysis_techniques.txt,DNARepairActivity_U2OS_Xray,Ancient_DNA_Isolation,Cytometry,Whole_Exome_Sequencing,Not_Reported,5h,30_years,Community,Silica_Dust,TB,ChIP_seq_analysis,Ext,Not_Assessed,Gross_Ext,Yes,Not_Applicable,Alt,M7_Acute_Megakaryoblastic_Leukemia,Leukaemia,patientX_preRx_read2.fastq,72.6%,69.5%,ninety-five,forty-five,Unk,'88,Control_Sample_DNA.maf,64KB,Proteome_data.csv,Disease_Progression,0-30D,Ocular_Alterations,SEQ89012E3,3yr_followup,500bp,five_fifty_bp,450bp,50.2_SD,NA,Pressure-assisted freezing,No,U,MYC_activation,ROBO2,scRNA_Seq_Analysis,Platypus_variant_caller,G2,P4,40%,low_grade,NR,7.2_cm,60800,96_hrs,Yes,1.55m,U,G2,H3Y,Absent,Pheochromocytoma_Paraganglioma,1500_copies_ml,Prog,Unk,Progesterone_mono,HPV-59,HPV-66,Not_Applicable,NR,Hodgkin_lymphoma_unspecified,Hodgkin lymphoma nodular sclerosis,individual_root,Not_Available,Ovarian,2023-Aug-09,IVC_Thrombosis,Pos,extremely_high,10.4,X-ray,Azathioprine,0,No,Sample_Collection,Unknown,50.6_kg,Poor_Prognosis,NR,Other_Technologies,2024-Oct-22,219mm,High_Intermediate_Risk,int_8,Group_1A,stage_3,Non-FFPE,1,3-4_Bridging_Fibrosis,80_normal_activity_with_effort,Not_Determined,Soluble_Mesothelin-Related_Peptides,L8,macro_>2cm,Unknown_status_not_reported,NA,2022-08-23T13:27:05+00:00,2022-05-25T14:50Z,octuple,Cancer_Virology_Library,NEB E7530,Thermo Fisher Ion AmpliSeq Library,Bio-Rad,Ion AmpliSeq Library Prep Kit v2.0,Ribosomal_RNA_Removal,NA,N6-Methyladenosine Immunoprecipitation Sequencing,seven,triaconta,PTEN_10q23.31,20.4cm,Followed_Up,MRND,Not_Otherwise_Specified,Pelvic,seven,seven,Absent,1200x,v8,4_cm,Positive,Ureter,Bereaved,Stage_4A,CGI_8532_Methyl_Dec,W110*_CDKN2A,Soft_tissue,c20ad4d76fe97759aa27a0c99bff6710_hash,350_fold_coverage,cm,ND,NR,Unknown,Absent,not_rptd,Retroperitoneal,Retrospective_Collection,Unreliable CpG Filtering,high,CGmap_to_Bismark_Conversion,Unknown,Positive,v8,RIP-seq,hsa-miR-221,Yes,Moderate,moderate,2.1k,Histology,Stop_Gain,Microsatellite Instability testing,Solid_growth,schwannoma_benign,intermediate,MSS,c.37G>A,V_Intensive,one_hundred_forty_five,LOWESS_norm_smooth,ucsf.edu,45%,Absent,Absent,Present,Not_available,No,U,Acetylsalicylic_Acid,Collection_Prohibited,High tumor growth rate,eight_hundred,dec,thirty_three,nine_hundred,18_years,X-ray Tech,Compound_Not_Used,Level_of_PD-L1_Expression,Not_Reported,Indeterminate,Yes,On-Demand_Oxygen_Therapy,twenty,two_forty,2013,Type_II,Urinary_sample,Absent,P8,pathogenic,e4a3bc7b-2e46-d7a2-573e-8d99d6f5ab,tumor_biopsy_only_with_distant_metastasis,Failure,NA,NA,Failure,NR,5.6%,72.8%,fifty_seven_percent,35.4%,28.7%,29.9%,11.7%,20.0%,49.6%,very_high,35%,26.3%,25.5%,58.8%,70.4%,NR,1_to_3,seven,Atyp,Pos,BreastCancer_HER2_Test,H8,Sequel,Unknown,PMID_32098765,14-15_servings,septiparous,Unknown,Y,Yes,400mg,Optimal_Cutting_Temperature_compound,Mantle cell lymphoma,Negative,G2,Cutaneous,Data_Not_Collected,Data_Not_Collected,DNA_analysis_bypassed,NA,Studies on Prostate Health,Yes,Olfactory_bulb,Biochemical_Recurrence,Prostate_Cancer_Epidemiology,LEUK-2023-STUDY_ALT,Tumorigenesis,2%,73%,93%,40%,94%,35%,seven,fifty,35%,ALK,ADVL0215,Unknown,Absent,Absent,Illumina_Mouse_450K,GC_Percentage,Sequel,350bp,NA,Schedule_Issues,octuple,215mm,Surgical_Intervention,immune_therapy,drug_response_data.tsv,twenties,UNK,Colorectal_Cancer,Child,No,Non-smoker,unk,seven,No,2023-Aug-20,1,Not_Published,Enabled,NR,R2_macroscopic_residual,<10_mm,Present,v8,35%,Absent,below_average,4.2,NR,Saturated_fat_intake,Gene_Expression_Profiling,below_average,Adenoma,IVes,histone_marks.bedgraph,eighth,Excluded_Sample,xenograft,very_high,Present,NR,F-18 NaF,4.4.4,Ex23,PML_MYLM,Glycan_profiling,Grade_3,NR,Esophageal,0,0,Included,No,Passed,Unknown,Sanger Inst,2022-Dec-01,NATIONAL CANCER INSTITUTE,5.1_cm,ATM_var,Interchrom_rearrangements,SmartSeq2,Thymus_gland,Cutaneous,octuple,7.3_cm,251-300nm,Wright_stained_multiple_myeloma,IHC,6:Not_Reported,DeepVariant,VarScan2_SNP,BIC_seq2,DeepVariant,S45F_CTNNB1,LOH_Testing,Lowry_Protein_Assay,100000 pM,A.lyrata_SpikeIns.fasta,29.3%,H_and_E,strong,Degraded_sample,Authorized,PindelSV,PD-L1_level_measurement,Illumina GSA,0.631,slight_gain,SRR0987654_unaligned.bam,NG88_RH,Temporal_lobe,U,Nextera_Exome,GGK700-GeneGuide,Roche_SeqCap_EZ_MedExome,BGI,xGen_Exome_Panel_v1.5,Not Overexpressed,mg/L,3.4_ng/mL,76-100,CD40 Agonist Antibody 2141-V11,Present,above_14_mg/L,21_minutes,40_min,not_reported,Preop,H08-35,Urinary_organs_overlapping_lesion,Cutaneous,1,Y1990,2014,1.75e6,eight_k_one_ninety_two,ENST00000445888,Positive,Penile,Ovarian,E4512_ALT,400mg,milligrams_per_square_meter,34_weeks,TSDT_Treatment_Stopped_Due_to_Toxicity,bid,Boost_Irradiation,treatment_given,10_months,Cancer_Immunotherapy,Cryosurgery,8.5_cm3,RMS,myeloma,NR,5.1_mm,7.8_mm,Recurrent,Solitary,Low,Not_Reported,Sparse,High,9.4_cm,Mid_zone,octaploid,25%,2_Stable_Disease,Infiltrative,3.1_mm,7.2_cm,version_iteration,Not_Specified,Vape,Stage_3C,T4,Stage_4,T3c,VIII,Absent,NR,4_years,Bilat,Surgical_Repair,NR,2023-08-05T18:50Z,seven_times,Acquired_variant,Repeat_Expansions,EMVI,HCV RNA,Unknown,postterm,Vein_invasion,very_high,H8,high_coverage,G2,Anaplastic,2024-02-25T10:15Z,https://github.com/cancer-therapy/workflow_v8/commit/j6k7l8m9n0,2023-08-18T15:30Z,Quality_Control,v4.2.0,MCMXXX,Y2022,Y2012,Y8,25,CZ,Homozyg
2.15,KIT_D816V,NR,HiSeq_Adapter,Illumina_adapter,Complex_EVM_Patterns,Present,Dermatologic Disorders,G2,26_years,early_fifties,adult,senior,Yes,RB1_variants,Unspecified,Unknown,N3b,Stage_IVB,LCIS_Tis,U,N3a,T4b_N0_M0,T2a,NR,half_day,very_heavy,Weekly,No,Teetotaler,Miscellaneous,Metastatic_Sample1_Read1.fastq.gz,S9_67890,Ribosomal_RNA_Removal,Mapping_and_Assembly_with_Qualities,3500ul,450ul,CSF,0.9g,clinical_study_notes.pdf,4.5ng/mL,ND,NR,450ul,Philadelphia_chromosome,Positive,Klinefelter_syndrome,NR,Additional_symptoms,IV,Unknown,Stage_1,S310F_ERBB2,Immunoglobulin_Heavy_Chain,PDB,U,Grunerite,twenty-seven point eight,550bp,275bp,No,Present,Strelka,Bonito_v0.2.5,Failure,B909,QR09,SD-Stab_Disease,Sinus Paranasales,L,ITS Supplement,Plt_min,calcium_serum_high,obese_class_2,2.39_m2,Absent,3.0_mm,Sporadic_BL_general,Early_Detection,Non_Hodgkins_lymphoma,HCM1_2526,Metrics_Change,Postoperative_Complications,Vital_Records,Other,six_hundred_seventy,Coagulation_Disorder,40K,Regional_Oncology_Centers,SCI,FAM,Cadmium compounds,NR,C,RG009_PT_E_TMR,I09-40,Unknown,H3K27trimethylation,translocation_9_11_p22_q23,8q,NR,non-smoker,50mm,level_1,in_transfer,Initial,N-acetyl-5-methoxytryptamine,N/A,Monoclonal,Absent,BIOLO-23-09,III,Unknown,IV,not_reported,No,End_Stage_Renal_Disease,Not_Reported,2.5mM,Death_Related,NR,4%,6%,Splenic,eight,annotation_metadata_xml,BICseq2_Liftover,neutral,FISH,Palestine,KI,cycle_9,2023-09-05T15:50Z,2021-03-09 00:00:00,Harold Varmus,94.5kg,17p13,Somatic_SV,Tarball_Gzipped,eXtensible Markup Language,PD-L1+,Genomic_Rearrangements,Drug_Response_Data,90d,18_weeks,-6 years,4_weeks,6_months,three_weeks,DOD_270,5_months,5_months,1_year,month_2_half,negative_1_week,4_weeks,9_months,9_months,16_months,-9,day_42,10_weeks,38.6_weeks,6_weeks,PHS000432,Health_Coverage,Genomic_Variation_Analysis,TZD,1,Unknown,octuple,UNK-Unknown,Mature_T_NK_Cell_Lymphomas,NA,SUPP-00901CC,ninety-six,s13045-019-0768-2,Absent,Negative,Cytokine,Not_Reported,NR,Not_Assessed,Bachelors_Degree,Low_Risk,Polyvinyl_Alcohol_Particles,ASCII33,IIA,U,E2,UNK,Absent,Present,50.0%,format_error,Low_Grade_Dysplasia,No,Not_Hispanic_Latino,Imaging_Evidence,Biopsy_Histologic_Confirmation,3-4_days,segment9,imaging_methods_summary.pdf,ProteinDegradation_SKBR3_Trastuzumab,miRNA_Isolation,IF,miRNA-seq,Not_Reported,6h,35_years,Not_specified,Tobacco_Smoke,Cryptorchidism,WGS_analysis,Ext,Not_Assessed,Micro_Ext,Yes,T4b_Very_Advanced,Rubious & Violaceous,Not_Classified,NHL,patientY_postRx_read1.fastq,85.0%,75.2%,eighty-two,seventy-six,Stage_III,'95,Prostate_Cancer_Sample8_ProteinArray.txt,128KB,Radiomic_features.csv,Disease_Relapse,0-30D,NR,SEQ90123F4,5yr_followup,550bp,six_hundred_bp,500bp,55.6_SD,NA,Bead freezing,Yes,U,CDKN2A_loss_of_function,RPS15A,Proteogenomics_Concordance,BCF_tools,G4,P5,45%,low_grade,Absent,8.8_cm,205100,108_hrs,No,1.7m,Positive_Response,G2,Not_Specified,Absent,LGG,2000_copies_ml,Unk,Active,Unknown,HPV-68,HPV-68,Vaginal_Margin,Not_Performed,Acute_myeloblastic_leukemia,Myeloid leukemia acute,pt_root,Unfavorable,Renal,2023-Sep-22,Data_Not_Available,NR,slightly_elevated,12.3,CT_scan,Cyclophosphamide,0,1,Genomic_Seq_Start,Residual_Dx,65.9_kg,Unknown,Metastatic_Special,SMRT,2025-Feb-12,242mm,High_Risk,int_9,Group_1B,stage_3,Non-FFPE,1,3-4_Bridging_Fibrosis,90_minor_signs_or_symptoms,Successful,CA_72-4,L9,macro_<=2cm,Local_recurrence_not_reported,L,2023-06-05T19:08:40+00:00,2023-03-10T15:25Z,nonuple,Oncolytic_Virus_Repository,KAPA HMR8455,Agilent SureSelect XT Target Enrichment,Pacific Biosciences,TruSeq DNA PCR-Free Kit v1,Other,FS,Single-Cell ATAC Sequencing,eight,tetraconta,RB1_13q14.2,23.1cm,NA,RND,Cervical,Unspecified,eight,eight,U,1500x,v9,5_cm,Positive,Renal_Vein,Bereaved,Stage_2B,CGI_9691_Stable,Q61R_NRAS,Splenic_nodes,c51ce410c124a10e0db5e4b97fc2af39_hash,400_fold_coverage,cm,Sonic_Hedgehog,NR,NR,Absent,regional_met,Spinal,Prospective_Collection,Genomic Position Correction,very_low,HumanMethylation450_Update,Unknown,Positive,v9,sRNA_cloning,hsa-miR-222,Yes,NR,high,1.9k,Unspecified,Stop_Retained_Variant,Tumor Mutational Burden analysis,Tubuliform,papillary_carcinoma_benign,intermediate,MSS,c.35G>A,IV_Severe,one_hundred_sixty_seven,raw_data,hopkinsmedicine.org,50.5%,Absent,Missing,Present,Absent,No,U,Paracetamol,Present,Tumor size decrease,nine_hundred,dodec,thirty_five,one_thousand_fifty,20_years,Cancer Nurse,Sample_Embedded,Status_of_MSI,Capsule_Fragmented,Positive,Yes,On-Demand_Oxygen_Therapy,twenty_five,three_thirty,2015,Type_II,Fecal_sample,Present,P9,variant_of_uncertain_significance,f1d2c35e-6f7a-8b9c-0d1e-2f3a4b5c6d,tumor_biopsy_only_no_distant_metastasis,Successful,Warning,NR,NA,SUCCESS,11.1%,80.4%,sixty_percent,40.0%,56.2%,33.3%,6.5%,23.5%,33.7%,extensive,40%,40.0%,30.3%,63.4%,82.1%,NR,NR,eight,Atyp,Neg,Ovarian_Cancer_Gene_Panel,I9,MiSeq,Near-diploidy,PMID_33289765,16-17_servings,octoparous,Tubal_Pregnancy,Y,No,450mg,Rapidly_Frozen,Medulloblastoma,Negative,G3,Urinary_Tract,Data_Not_Collected,Unknown,DNA_seq_skipped,NA,Hematologic Cancer Investigations,Yes,Digestive_system_overlapping_lesion,Unknown,Leukemia_Resistance_Mechanisms,SKIN-CANCER-18_ALT,Targeted_Therapy,2.3%,85%,91%,45%,85%,40%,eight,fifty_five,40%,KRAS,ANBL0322,White,NR,Present,Affymetrix_Promoter_1.0,Median_Insert_Size,GAIIx,400bp,NA,Unknown,nonuple,247mm,Unknown_Status,precision_medicine,outcome_analysis.R,twenties,M,Oropharyngeal_Cancer,Monozygotic_Sibling,NR,Non-smoker,unk,eight,Y,2023-Sep-05,N,Not_Published,Not_Applicable,No_Residual_Tumor,R0_no_residual_tumor,<10_mm,Absent,v9,40%,Absent,below_average,3.6,Present,Sedentary_lifestyle,CLIP_Seq,poor,Fibroma,TD,alternative_splicing.sam,ninth,Pleural_Fluid,foreign_material,extensive,Absent,Positive,F-18 NaF,5.0.1,Ex26,SS18_SYT,Metabolomics,Grade_3,Absent,Vesical,No,Yes,Yes,No,NA,NR,BGI,2023-Feb-14,FRED HUTCH,0.5_cm,CHEK2_var,Intrachrom_rearrangements,Chromium_3p_GEX_v3,Colon_transverse,Pleural,nonuple,8.8_cm,301-350nm,Silver_impregnation_neuroendocrine_tumor,FISH_technique,5:Status_Unknown,Pindel,VarScan2_Indel,Control_FREEC,Platypus,E1202K_ALK,Gene_Expression_Analysis,Biophotometer_Plus,200000 pM,Yeast_tRNA.fasta,38.6%,H_and_E,moderate,Incomplete_data,Authorized,CNVnator,NTRK_fusion_detection,Affymetrix 250K Nsp/Sty,0.774,normal,SRR5678901_unaligned.bam,OG12_SI,UNK,No,SureSelect_Exon_v4,9000TC-PureSeq,Agilent_SureSelect_CRE,Twist,NEBNext_Direct_Cancer_Panel_v2.1,Detected,mg/dL,8.7_ng/mL,<1,Fosgemcitabine,Absent,>14_milligrams_per_liter,24_minutes,45_min,not_reported,Pre_Treatment,I09-40,Bladder_posterior_wall,Renal,No,Y2005,2016,2e6,sixteen_k_three_eighty_four,NM_000059,NR,Popliteal_Space,Cutaneous,A081801_ALT,450mg,milligrams_per_milliliter,38_weeks,U_Unknown,biw,Not_Specified,treatment_given,11_months,External_Beam_Radiation_3D,Thermal therapy,9.9_cm3,STS_non-RMS,adenocarcinoma,N,7.6_mm,1.5_mm,Unknown_Status,NA,NR,Grade_3,Intermediate,High,6.7_cm,Anterior_horn,nonaploid,15%,2_Stable_Disease,Convex,3.5_mm,2.1_cm,data_version,Garbage_burning_smoke,Water_Pipe,Stage_4B,T4e,Stage_4B,T4,NR,Absent,Present,4.5_years,Bilat,Orchidectomy,NR,2023-09-21T13:35Z,eight_times,Not_specified,Subst,Macrovascular_Invasion,NR,Unknown,term_full,Sinusoid_invasion,extremely_high,I9,no_coverage,G1,Favorable_Histology,2024-03-30T19:00Z,https://github.com/genomic-data-analysis/workflow_v9/commit/o1p2q3r4s5,2023-09-05T09:00Z,RNA_Seq_Counts,v5.0.0,MCMXXXIV,Y2023,Y2013,Y9,30,CZ,Nullizyg
2.20,EGFR_C797S,Warning,NovaSeq_Adapter,Nextera_adapter,Chemoresistant,NR,Testicular Hemorrhage,G5,35_years,late_fifties,senior,elderly,Y,ALK_variants,Salmonellosis,cM0_i_plus,NR,Stage_X,Pagets_Tis,cM0i_plus,N4,T4c_N0_M0,T3a,UNK,one_and_half_days,light,Yearly,No,Sobriety,Vinous_Alcohol,Metastatic_Sample1_Read2.fastq.gz,S10_12345,mtDNA_Removal,Comprehensive_Read_Architecture_Classification,5000ul,500ul,Pleural_effusion,1g,radiology_images_data.zip,1.8ng/mL,ND,Deoxyribonucleic_Acid,500ul,Epidermal_Growth_Factor_Receptor,Localized,XXY,NR,Diaphoresis_nocturnal,IV,NR,Stage_3,Q61R_NRAS,Cytoplasmic_Ig,HPA,Absent,Grunerite,thirty-four point five,600bp,300bp,No,NR,lofreq,Guppy_v4.2.2,NA,B1010,ST10,TE-Early_Evaluation,Orchis,Unk,B27,Bil_min,hemoglobin_A1c_upper,obese_class_2,2.5_m2,NR,3.5_mm,Unknown_BL_adult,Monitoring,Cutaneous_melanoma,HCM1_2829,Tumor_Normal_Appearance,Poisoning,Unk,Progression,five_hundred_ten,Coagulation_Disorder,45K,Oncology_Treatment_Centers,UCMCC,FAM,Radon-222,NR,C,RG010_PT_E_NRM,J10-45,H3K27ac_antibody_ab4729,Control,NA,9q,NR,non-smoker,55mm,level_3,confirmed,Relapse,Zingiber officinale,F,Monoclonal,Present,DATAS-23-10,IV,Unknown,IV,not_reported,No,Sarcoidosis,Clinical_Assessment,3mM,Waiver,N,4.5%,8%,Large_Intestine,nine,validation_assays_CNV_docx,CNVer_GenomeLiftover,neutral,Single-Cell Genomics,Sweden,SA,cycle_10,2023-10-10T12:00Z,2021-03-10 00:00:00,Bert Vogelstein,58.6kg,19q13,SV,Tagged_Image_File_Format,JavaScript Object Notation,MSI-H,Raw_Sequence_Data,Immuno_Profile_Data,105d,20_weeks,-22 years,5_weeks,7_months,four_weeks,DOD_300,6_months,6_months,13_months,month_3,baseline,5_weeks,10_months,10_months,20_months,-10,day_50,12_weeks,42.9_weeks,8_weeks,PHS000433,Cancer_Family_History,Treatment_Efficacy_Data,UNK,1,No,nonuple,WT-Present,Myxoid_Neoplasms,NA,SUPP-01011BL,sixty-seven,s41591-019-0508-4,Absent,Negative,Cytokine,Not_Reported,Other_Dysplasia,Data_Missing,Postgraduate_Degree,Intermediate_Risk,Ethiodized_Oil,ASCII64,III,M1,NR,cM0_i_plus,Present,Present,55.6%,checksum_failure,Not_Reported,No,Not_Collected,Imaging_Evidence,Imaging_Evidence,missing,segment10,stats_methodology_plan.docx,MetabolicProfiling_HepG2_Sorafenib,Noncoding_RNA_Isolation_Melanoma,TMA,single_cell_ATAC-seq,Unknown,7h,40_years,Not_specified,Chewing_Tobacco,Cardiovascular_Disease,Metab_profiling,Ext,Not_Assessed,Gross_Ext,Yes,T4a_Moderate_Advanced,Griseous,M2_Acute_Myeloblastic_Leukemia_With_Maturation,Thyroid_neoplasms,patientY_postRx_read2.fastq,67.5%,81.6%,one hundred twenty,eighty-eight,NR,'88,Breast_Cancer_Patient9_FluorescenceInSituHybridization.jpeg,256KB,Treatment_Outcome.docx,Secondary_Cancer,0-30D,Neurosensory_Alterations,SEQ01234G5,Recurrence,600bp,six_fifty_bp,550bp,49.1_SD,NA,Constant temperature freezing,Yes,U,PIK3CA_alteration,ZNF198,SV_Annotation,Sentieon_genomics_DNAseq,G2,P4,50%,low_grade,NR,9.4_cm,175000,120_hrs,No,1.78m,Positive_Response,G2,macroH2A,NR,Pheochromocytoma_Paraganglioma,2500_copies_ml,Unk,None,Unknown,Other_types,HPV-73,Not_Applicable,Hysterectomy_SPEC,Malignant_neoplasm_of_ovary_unspecified,Malignant neoplasm of ovary unspecified,subject_root,Not_Available,Thyroidal,2023-Oct-13,Renal_Metastasis,Pos,above_average,8.6,CT_scan,Methotrexate,Completed,Yes,Enrollment_Date,Unknown,70.0_kg,Unknown,Localized_1,Protein_Arrays,2025-Apr-07,275mm,High_Intermediate_Risk,int_10,NR,stage_3,Fresh,0,1-2_Portal_Fibrosis,unknown,Warning,Total_Serum_Protein,L10,macro_>2cm,Distant_metastasis_not_reported,Uni,2014-09-17T20:50:25+00:00,2021-08-30T17:45Z,decuple,Neoantigen_Repository,Agilent 5190-8863,New England Biolabs NEBNext Ultra RNA,ONT (Oxford Nanopore),NEBNext Ultra DNA Prep Kit v2.1,Other,US,Single-Cell RNA Sequencing,nine,pentaconta,ERBB2_17q12,25.5cm,NA,FND,Not_Otherwise_Specified,Retroperitoneal,nine,nine,NR,2000x,v10,6_cm,Negative,Renal_Vein,Bereaved,Stage_1,CGI_10785_Methyl_Inc,E1202K_ALK,Thyroidal,aab3238922bcc25a6f606eb525ffdc56_hash,450_fold_coverage,cm,Non-WNT/Non-SHH,Absent,NR,Unk,not_rptd,Urethral,Prospective_Collection,Signal-to-Noise Enhancement,high,Oxford_Nanopore_Methylation_to_hg19,NR,NR,v10,LNA_techniques,hsa-miR-17,Yes,Minimal,high,2.2k,NR,Transcription_Factor_Binding_Site_Amplification,NTRK fusion analysis,Micropapillae,myeloid_leukemia_chronic,low,MSI-H,c.37G>A,V_Intensive,one_hundred_ninety,segmented_data,fhcrc.org,60%,Absent,Absent,Present,Absent,No,U,Glucophage,Data_Not_Submitted,Symptomatic relief reported,one_thousand,pentadec,thirty_seven,one_thousand_two_hundred_fifty,23_years,Data Analyst in Clinical Research,Sample_Not_Embedded,Performance_Status_ECOG,Capsule_Ruptured,NR,Yes,On-Off_Oxygen_Therapy,thirty,two_ten,2017,Type_1,Cutaneous_biopsy,Absent,P10,variant_of_uncertain_significance,g2h3i4k6-l7m8-n9o0-p1q2-r3s4t5u6v7,tumor_confined_kidney_no_distant_metastasis,Warning,Successful,NR,Failure,FAILURE,8.4%,85.9%,sixty_two_percent,45.2%,3.5%,37.5%,8.9%,26.8%,25.4%,low,45%,15.6%,40.0%,69.1%,89.6%,U,>3,nine,Inadequate,NR,ProstateCancer_AndrogenReceptor_Splice,J10,GS FLX,NR,PMID_34567892,18-19_servings,nonaparous,NR,U,U,500mg,No_Information,Mucinous borderline ovarian tumor,Negative,G3,External_Female_Genitalia,Data_Not_Collected,No,DNA_analysis_bypassed,Gastrointestinal_Scopy,Public Health & Cancer Prevention Strategies,Not_Collected,Uterine_parametrium,Biochemical_Recurrence,Glioblastoma_Treatment_Strategies,PROST-DETECT-17_ALT,Endocrine_Treatment,2.5%,90%,90%,50%,91%,45%,nine,sixty,45%,PDGFRA,CCG2961,AI_AN,Present,NR,NimbleGen_Mouse_385K,Coverage_by_Read_Group,GridION,450bp,Read1,Patient_Refusal,decuple,289mm,Histamine2_Receptor_Antagonists,radiotherapy,genetic_markers.sql,thirties,UNK,Nephroblastoma,Not_Related,NR,Unknown,unk,nine,N,2023-Oct-10,Yes,Not_Available,Not_Applicable,No_Residual_Tumor,R2_macroscopic_residual,<10_mm,Present,v10,45%,Absent,below_average,2.8,U,Human_papillomavirus_infection,Capture_Sequencing,very_poor,Sarcoma,Rec,sample_purity.txt,tenth,Post_Chemotherapy,primary_tumor,high,Present,Unknown,F-18 NaF,5.5.5,Ex29,ZMYM3_ZNF198,Transcriptomics,Grade_3,NR,Renal,1,Yes,0,0,NA,NR,EMBL,2023-May-07,SEATTLE CANCER CARE ALLIANCE,3.3_cm,PALB2_var,LOH,SmartSeq2,Urachus,Renal,decuple,2.2_cm,351-400nm,Alcian_blue_stained_pancreatic_cancer,Cryosections,5:Status_Unknown,TN_pair_analysis,Pindel,Sequenza,TN_Pairing,S310F_ERBB2,ctDNA_Methylation_Testing,DirectDetect,500000 pM,Human_rRNA.fasta,9.4%,IHC,weak,Ethical_approval_awaited,Authorized,Strelka2SV,MMR_status_assessment,Illumina Exome Array,0.211,slight_loss,SRR1098765_unaligned.bam,PG77_TJ,White_matter,No,TruSeq_Cancer_Panel,OC100-OncoCapture,Illumina_TruSight_One,PacificBiosciences,SureSelect_Clinical_Exome_V2,Quantitative Measure Available,mm_squared,5.5_ng/mL,Not_Reported,Tebentafusp,Absent,>14_mg_per_L,27_minutes,50_min,6-30_min,Post_Surgery_3M,J10-45,Bones_of_thorax,Cerebral,No,Y1978,2018,2.25e6,thirty_two_k_seven_sixty_eight,NM_004360,NR,Scrotal,Cervical,E4512_ALT,500mg,milligrams_per_week,43_weeks,VGPR_Very_Good_Partial_Response,unknown,Hormone_Therapy,treatment_given,12_months,Systemic_Radioisotope_Therapy,PDT,11.2_cm3,WT,squamous_cell_carcinoma,NR,9.0_mm,2.8_mm,Experimental_Model,Solitary,Unknown,Grade_4,Sparse,High,0.8_cm,Posterior_horn,decaploid,5%,2_Stable_Disease,Not_Specified,4.0_mm,8.5_cm,release_version,Occupational_smoke_fog_machines,Cigarillo,Stage_4C,DCIS,Stage_4C,T4a,UNK,NR,NR,5_years,Bilat,Surgical_Repair,R,2023-10-11T15:05Z,nine_times,Not_specified,Transloc,Microvascular_Invasion,UNK,Deceased,preterm_early,Capsule_invasion,maximal,J10,very_high_coverage,Unknown,NA,2024-04-18T08:30Z,https://github.com/targeted-therapy/workflow_v10/commit/t6u7v8w9x0,2023-10-13T14:15Z,Variant_Calling,v5.3.2,MCMXXXVIII,Y2024,Y2014,Y10,35,PZ,Homozyg
1.70,AKT1_E17K,Warning,SMRTbell_Adapter,TruSeq_adapter,High_grade_dysplasia,NR,Loose Stools,G2,65_years,early_sixties,elderly,advanced_age,Y,ERBB2_amplifications,Toxo,M1,N0_mol_pos,Stage_IIIC,DCIS_Tis,M1c,N3a,NR,T3b,II,two_and_half_days,moderate,Monthly,No,Frequent_Drinker,Spirits,Tumor_Sample3_Read1.fastq.gz,S11_23489,Viral_Integration_Mapping,CLC_Genome_Workbench,1250ul,550ul,Ascitic_fluid,1.2g,drug_response_data.sql,3.2ng/mL,NR,Protein,550ul,Kirsten_Rat_Sarcoma_Viral_Oncogene,Localized,Klinefelter_syndrome,Present,Pyrexia,III,NR,Stage_1,R132H_IDH1,Kappa_Light_Chain,cBioPortal,Present,Riebeckite,twenty-nine point nine,650bp,325bp,0,Present,GATK_Mutect2,Albacore_v2.2.7,Successful,B1111,UV11,RD-Resp_Disease,Gaster Fundus,Bilat,N2,Cl_min,neutrophil_count_max,obese_class_3,2.61_m2,Present,4.0_mm,Sporadic_BL_general,Monitoring,BCC,HCM1_3132,Specimen_ID_unknown,Cause_Unknown,Health_Record,Treatment_Completion,three_hundred_fifty,PWID,50K,Molecular_Cancer_Centers,MGHCC,FAM,Diesel particulate matter,No,Unknown,RG011_PT_F_TMR,K11-50,H3K27ac_antibody_ab4729,Control,translocation_11_19_q23_p13.1,4q,NR,moderate_smoker,60mm,NR,available,Pre-cancerous,Zincum metallicum,N/A,Monoclonal,Present,PHARM-23-11,NR,Unknown,II,intermediate_risk,Not_Reported,Inflammatory_Bowel_Disease,Not_Reported,5mM,Full_Consent,Y,5%,12%,IVC,ten,CN_gain_loss_map_svg,BreakDancerMax_Liftover,neutral,3C Technology,Micronesia,BZ,cycle_11,2023-11-25T18:25Z,2021-03-11 00:00:00,Tony Hunter,102.3kg,2p21,Methylation_Data,Tarball_Gzipped,Mutation Annotation Format,HNPCC,CN_Levels_By_Gene,PROs,120d,22_weeks,-27 years,6_weeks,8_months,five_weeks,DOD_330,7_months,7_months,15_months,month_4,positive_1_week,6_weeks,11_months,11_months,24_months,-11,day_60,14_weeks,47.1_weeks,10_weeks,PHS000434,BMI,X-ray_Reports,NR,No,No,decuple,PR-Partial Remission,Mature_B_Cell_Lymphomas,NA,SUPP-01122ML,fifty-nine,cd-19-0568,NR,Negative,Cytokine,Low_Grade,Esophageal_Mucosa_Dysplasia,1_Restricted_in_Physically_Strenuous_Activity,Postgraduate_Degree,Not_Specified,Ethiodized_Oil,Illumina_v1.9,III,M0,E2,NA,Absent,Absent,62.1%,checksum_failure,Unknown,No,Hispanic_Latino,Imaging_Evidence,Imaging_Evidence,3-4_days,segment11,research_ethics_docs.pdf,ImmuneResponse_LC540_CBDCA,RNA_Isolation,In Vitro Assays,SNP_Genotyping_Array,Not_Reported,8h,45_years,Community,Coal_Dust,Familial_Ovarian_Cancer,miRNA_expr_analysis,Ext,Not_Assessed,Gross_Ext,Yes,T3_Minimal,Amber,M4_Acute_Myelomonocytic_Leukemia,Renal_cancer,ctrl_grp1_read1.fastq,90.3%,70.3%,sixty-four,one hundred three,NR,'09,Colon_Cancer_Sample10_GeneChip.tif,512KB,Genomic_Mutations.maf,Secondary_Cancer_Deceased,0-30D,NR,SEQ12345H6,Post_tx_monitoring,650bp,seven_hundred_bp,600bp,43.8_SD,NA,Vacuum-assisted freezing,No,NR,ESR1_repression,CARS1,Somatic_Mutation_Consolidation,DRAGEN_Germline,G2,P4,55%,low_grade,NR,10.5_cm,25600,132_hrs,Unknown,1.65m,NR,NR,H31,NR,LGG,3000_copies_ml,NR,Active,NR,HPV-59,HPV-33,Urinary_Bladder,Not_Performed,Malignant_neoplasm_of_endometrium,Follicular lymphoma grade II,subject_root,Favorable,Cutaneous,2023-Nov-03,Data_Not_Available,Unknown,very_low,14.7,X-ray,Unknown,0,1,Sample_Collection,NR,75.3_kg,Unknown,NR,Illumina_450K,2025-Jun-29,308mm,Low_Intermediate_Risk,int_11,Group_2C,NR,Non-FFPE,No,Not_Reported,70_cares_for_self,Not_Available,HPV,L11,macro_>2cm,Biochemical_recurrence_not_reported,Uni,2013-12-03T22:31:50+00:00,2022-10-07T13:00Z,dodecuple,Radiogenomics_Data_Archive,Thermo Fisher 4471252,Illumina TruSeq Stranded Total RNA,Merck (Sigma-Aldrich),SureSelectXT Methyl-Seq Library Prep Kit v1.0,Sequence_Capture,FS,N6-Methyladenosine Immunoprecipitation Sequencing,ten,hexaconta,ABL1-BCR_22q11.23,28.9cm,Not_Followed_Up,MRND,Right_axillary,Splenic_hilum,ten,ten,U,2500x,v11,7_cm,Positive,Gerotas_Fascia,Single,Stage_4A,CGI_11820_Methyl_Dec,D1010N_MET,Maxillary,9bf31c7ff062936a96d3c8bd1f8f2ff3_hash,500_fold_coverage,mm,Wingless_Pathway,NR,Unknown,Present,distant_met,Vertebral_Column,Prospective_Collection,Epigenetic Cell Composition Analysis,low,MethylKit_Transformation_Workflow,NR,Unk,v11,next_generation_sequencing,hsa-miR-92a,NR,NR,high,1.6k,Quantitative_real-time_PCR,miRNA_Variant,BCR-ABL fusion detection,Discohesive,carcinoma_nos,high,MSS,c.181C>A,V_Intensive,two_hundred_ten,LOWESS_normalization,nci.nih.gov,68.3%,Absent,Missing,NA,Absent,No,U,Glucophage,Present,Chemotherapy intolerance,eleven_hundred,octadec,forty,one_thousand_five_hundred,25_years,Computational Biologist,Positive,Type_of_Molecular_Subtype,Not_Reported,Indeterminate,NR,On-Demand_Oxygen_Therapy,thirty_five,one_fifty,2019,Type_I,Hepatic_biopsy,Absent,P15,pathogenic,h7g8f9d1-c2b3-a4s5-d6f7-g8h9i0j1k2,tumor_confined_kidney_no_distant_metastasis,NR,NR,NA,NA,UNK,4.3%,90.2%,sixty_five_percent,50.6%,62.8%,40.0%,13.6%,30.2%,18.9%,low,50%,21.9%,50.7%,74.5%,90.5%,U,1_to_3,ten,Atyp,Pos,Thyroid_BRAF_Mutation_Test,K11,CytoScan,NR,PMID_35678901,20-21_servings,decaparous,Termination_of_Pregnancy,U,U,550mg,Collection_Forbidden,NF1,No,G3,Female_Genital_Tract_NOS,Data_Not_Collected,Data_Not_Collected,sequencing_not_performed,Gastrointestinal_Scopy,Studies in Cancer Genetics,No,Abdominal_soft_tissues,Regional_Metastasis,Colorectal_Cancer_Diagnostic_Advancements,COLON-CR-2023_ALT,Pluripotent_Stem_Cell_Study,2.8%,78%,89%,55%,96%,50%,ten,sixty_five,50%,CD20,NCT003881,NA,NR,NR,Agilent_Methyl-Seq,Pct_Q30_Bases,HiSeq_X,500bp,Read3,Unknown,undecuple,321mm,Antacid_Therapy,hematopoietic_stem_cell_transplantation,survey_responses.sav,forties,M,Urothelial_Carcinoma,Not_Related,No,Non-smoker,unk,ten,Yes,2023-Nov-25,N,Available,Not_Applicable,No_Residual_Tumor,RX_cannot_be_assessed,>20_mm,Not_reported,v11,50%,Present,average,2.1,Present,Ionizing_radiation,Direct_RNA_Seq,critical,Lymphoma,SL,tcr_seq.fasta,eleventh,Primary_Carcinoma,primary_blood_derived,moderate_low,Present,Uncertain,F-18 Fluciclovine,6.0,Ex32,LYL1_LYLF,Assay_for_transposase-accessible_chromatin_using_sequencing,Grade_3,NR,Thyroidal,1,Yes,Included,No,NA,Warning,JHU Genomics,2023-Jul-21,BRIGHAM WOMEN'S,6.0_cm,PMS2_var,Amp,Chromium_3p_GEX_v2,Adnexa_uteri,Splenic,undecuple,4.6_cm,401-450nm,Congo_red_stained_amyloidosis_in_myeloma,PAS_stain,5:Status_Unknown,SomaticSeq,TN_Pairing_Analysis,XHMM,GATK_HaplotypeCaller,D1228N_MET,RNA_Splicing_Test,Fluorometry,1 uM,Drosophila_Spike.fasta,51.2%,IHC,very_strong,Sequencing_mistake,Authorized,GATKSV,CDKN2A_inactivation_study,Agilent CGH+SNP Microarray,0.598,gain,SRR6789012_unaligned.bam,CC41_PK,NR,No,MSK_IMPACT_468,PTK200-PrimeTarget,IDT_xGen_Exome_Research_v1.0,NEB,TruSight_One_Panel,Moderate,g/dL,11.0_ng/mL,51-75,CD40 Agonist Antibody 2141-V11,U,>14_milligrams_per_liter,30_minutes,55_min,31-60_min,Adj_Therapy,K11-50,Anal_region,Gastric,1,Y1985,2019,2.5e6,sixty_five_k_five_thirty_six,NM_001005862,NR,Cardiac,Esophageal,E4512_ALT,550mg,milligrams_per_day,47_weeks,PD_Persistent_Disease,qw,Prophylaxis,no_treatment,13_months,Radiomodification_Therapy,Laser ablation,12.8_cm3,RT_kidney,leukemia,NR,10.5_mm,3.0_mm,Unknown_Status,Solitary,Grade_X,Grade_3,Intermediate,High,11.3_cm,Lateral_horn,undecaploid,90%,3_Progressive_Disease,Not_Specified,4.5_mm,4.3_cm,iteration_release,Industrial_smoke_plastics,Vape,Stage_1A,Tis_DCIS,Stage_1B1,TX,VII,Present,Present,6_years,Bilat,Natural_Resolution,NR,2023-11-02T11:25Z,ten_times,Not_specified,Gene_Conversion,Absent,Hepatitis B Virus DNA,LTFU,term_full,Tumor_size_>10cm,maximal,K11,low_coverage,NR,Anaplastic,2024-05-22T15:45Z,https://github.com/cancer-immunotherapy/workflow_v11/commit/y1z2a3b4c5,2023-11-02T08:45Z,RNA_Seq_Counts,v6.0.0,MCMXLII,Y2025,Y2015,Y11,40,CZ,Homozyg
1.65,TP53_R249S,Failure,Nanopore_Adapter,Custom_adapter,C_diff_infection,NR,Dermatologic Disorders,G5,80_years,retirement_age,adult,late_life,Yes,MET_amplifications,HIV_wasting,Unknown,N1bi,Stage_IV,T1b,NA,N1c,T3_N0_M0,T3b,VI,three_and_half_days,light,Weekly,No,Frequent_Drinker,Spirits,Tumor_Sample3_Read2.fastq.gz,S12_34501,Hypermutation_Adjustment,Primer_Annotation_Genome_Improvement_Toolkit,2750ul,600ul,Frozen_lymph_node_biopsy,1.4g,pathology_images_annotations.pickle,6.0ng/mL,Adjacent_to_Tumor,NR,600ul,Anaplastic_Lymphoma_Kinase,Generalized,Monosomy_X,NR,Weight_reduction,IV,Unknown,Stage_3,W110*_CDKN2A,Surface_Ig,GDAC_Firehose,Present,Grunerite,thirty-one point two,700bp,350bp,No,NA,VarScan2,Bonito_v0.1.3,Successful,B1212,WX12,PR-Part_Response,Nodi Lymphoidei Supraclaviculares,L,HSA,Creat_min,lymphocyte_count_upper,obese_class_3,2.72_m2,Present,4.5_mm,NA,Early_Detection,SCC,HCM1_3435,QC_Failure,Cause_Unknown,Vital_Records,Deceased,eight_hundred_eighty,PWID,55K,Immunotherapy_Cancer_Centers,NU RHLC,FAM,Crystalline silica,Yes,C,RG012_PT_F_NRM,L12-55,NA,H3K9trimethylation,NR,11q,NR,non-smoker,65mm,level_5,completed,Concurrent_primary,Linseed Oil,T,Monoclonal,Present,CELLU-23-12,U,Unknown,IV,intermediate_risk,Not_Reported,Idiopathic,Clinical_Assessment,10mM,Waiver,NR,5.5%,9%,Large_Intestine,eleven,CNV_histograms_png,GenomeSTRiP_StructuralVariantLiftover,neutral,OGM,PRC,JE,cycle_12,2023-12-30T20:00Z,2021-03-12 00:00:00,Dennis Slamon,110.5kg,4q25,Raw_Reads,Tagged_Image_File_Format,Sequence Alignment/Map,PIK3CA+,Patient_Metadata,EHRs,150d,24_weeks,-32 years,7_weeks,9_months,six_weeks,DOD_365,8_months,9_months,16.5_months,month_5,positive_2_weeks,7_weeks,12_months,12_months,26_months,-12,day_75,18_weeks,52_weeks,12_weeks,PHS000435,Tobacco_Use,Operative_Notes,TZD,1,No,undecuple,PR-Partial Remission,Mature_T_NK_Cell_Lymphomas,Remote_>2cm,SUPP-01233TC,one hundred twenty,ccell202003012,Absent,NR,Cytokine,Severe,Esophageal_Mucosa_Dysplasia,Data_Missing,Postgraduate_Degree,Not_Specified,Ethiodized_Oil,NextSeq500,IA,NR,NR,M2,NR,Present,68.3%,checksum_failure,High_Grade_Dysplasia,No,Unknown,Imaging_Evidence,Biopsy_Histologic_Confirmation,missing,segment12,cell_origin_details.xlsx,CancerStemCells_K562_Nilotinib,Ancient_DNA_Isolation,In Vivo Modeling,Protein_Array,Unknown,10h,50_years,Domestic,Tobacco_Smoke,Cardiovascular_Disease,qPCR_analysis,Ext,Not_Assessed,Micro_Ext,Yes,T4a_Moderate_Advanced,Griseous,Not_Classified,Urothelial_carcinoma,ctrl_grp1_read2.fastq,62.8%,77.9%,one hundred seven,sixty-five,Unk,'09,Leukemia_B_subtype_clinicalData.pdf,1MB,Patient_Outcome.xlsx,Missing,0-30D,Neuromotor_Alterations,SEQ23456I7,NED,700bp,seven_fifty_bp,650bp,58.3_SD,Unknown,Nitrogen slush freezing,U,U,MDM2_overexpression,ROBO2,Germline_Variant_Integration,Joint_Genotyping,G1,P4,60%,low_grade,Present,11.1_cm,130200,144_hrs,Unknown,1.6m,U,NR,H2AZv2,NR,Pheochromocytoma_Paraganglioma,4000_copies_ml,Unk,Active,Progesterone_mono,HPV-33,HPV-18,Micro_Parametrium,Not_Performed,Malignant_neoplasm_of_thyroid_gland,Lymphoid leukemia acute,pt_root,Not_Available,Osseous,2023-Dec-01,Data_Not_Available,Pos,near_average,16.2,CT_scan,Not_Reported,Completed,1,Enrollment_Date,NR,80.6_kg,Poor_Prognosis,Metastatic_Special,Illumina_27K,2025-Sep-03,341mm,High_Risk,int_12,Group_4,UNK,Paraffin-Embedded,No,3-4_Bridging_Fibrosis,40_disabled,Failure,Beta-hCG,L12,macro_>2cm,Biochemical_recurrence_not_reported,NR,2012-10-20T23:13:15+00:00,2023-01-22T09:55Z,pentadecuple,Chemoresistance_Genome,Illumina 20015964,Takara Clontech SMART-Seq v4,PerkinElmer Inc.,TruSeq Stranded mRNA Library Prep Kit v3,Amplification,FS,Ribonucleic Acid Sequencing,twelve,heptaconta,MSH2_2p22.2,31.2cm,Not_Followed_Up,MRND,Left_axillary,Submandibular,eleven,twelve,U,3000x,v12,8_cm,Positive,Renal_Vein,Single,Stage_4B,CGI_12945_Stable,S310F_ERBB2,Soft_tissue,70efdf2ec9b086079795c442636b55fb_hash,550_fold_coverage,cm,ND,Absent,Post-menopausal,Unk,distant_met,Nodal,Prospective_Collection,Demographic Factors Normalization,very_high,BSMAP_to_MethPipe_Conversion,NR,Unk,v12,stem-loop_qRT-PCR,hsa-miR-205,NR,Moderate,high,1.4k,DNA_sequencing,UTR5_Variant,CD20 level analysis,Solid_growth,bronchioloalveolar_carcinoma,high,Microsatellite_stable,c.35G>A,IV_Severe,two_hundred_thirty,hg19_reference,mayo.edu,75%,Absent,Present,Present,Absent,No,U,Glucophage,Absent,Tumor-free surgical margins,twelve_hundred,vigint,forty_five,one_thousand_eight_hundred,28_years,Public Health Officer,Negative,Burden_of_Tumor_Mutations,Capsule_Fragmented,Unknown,Yes,On-Off_Oxygen_Therapy,forty,two_seventy,2021,Type_I,Pulmonary_biopsy,Absent,P20,likely_pathogenic,i9h8g7e5-d4c3-b2a1-s0f9-e8d7c6b5a4,tumor_biopsy_only_with_distant_metastasis,NA,NA,NA,Failure,NR,6.9%,93.7%,sixty_seven_percent,55.8%,18.9%,45.2%,5.3%,33.7%,12.5%,minimal,55%,4.4%,60.5%,79.2%,92.3%,NR,1_to_3,twelve,Atyp,NR,LiverCancer_AFP_Assay,L12,nCounter,Near-diploidy,PMID_36789012,22-23_servings,undecaparous,Tubal_Pregnancy,Y,No,600mg,Collection_Prohibited,Mesonephric adenoma,Negative,G3,Central_Nervous_System,Data_Not_Collected,Data_Not_Collected,sequencing_not_performed,Gastrointestinal_Scopy,Advances in Radiotherapy,Yes,Abdominal_soft_tissues,Metastasis,Ovarian_Cancer_Marker_Research,HEMATO-ONC-16_ALT,DNA_Mutations,3%,94%,88%,60%,86%,55%,twelve,seventy,55%,MDM2,ADVL0215,B_AA,Absent,Present,ONT_MinION,Adapter_Sequence_Content,Proton,550bp,Read1,Adverse_Events,duodecuple,356mm,NA,mAbs,clinical_lab_results.csv,sixties,UNK,Myeloid_Leukemia,Foster_Sibling,No,Non-smoker,unk,eleven,Y,2023-Dec-30,No,Available,Not_Applicable,NR,R2_macroscopic_residual,10-20_mm,Absent,v12,55%,Present,average,1.5,NR,UV_exposure,T_Cell_Receptor_Sequencing,almost_degraded,Myeloma,IT,gene_diff_expression.csv,twelfth,Excluded_Sample,normal_tissue,extensive,Present,Positive,F-18 NaF,6.6.6,Ex35,PML_MYLM,Integrated_proteogenomics_analysis,Grade_3,NR,Cutaneous,0,1,Included,Yes,Warning,Unknown,DFCI,2023-Aug-30,UPMC HILLMAN,1.4_cm,STK11_var,Point_mut,SmartSeq2,Palatine_uvula,Pancreatic,duodecuple,3.3_cm,451-500nm,Toluidine_blue_stained_mastocytoma,Trichrome_stain,4:Data_Not_Collected,FACETS_copy_number,Haplotype_Caller,PURPLE,FreeBayes,Q61R_NRAS,ncRNA_Assessment,Colorimetric_Protein_Assay,2.5 uM,C.elegans_miRNA.fasta,60.8%,H_and_E,weak,Suspected_mix-up,Authorized,TIDDITSV,BCR_ABL_fusion_detection,Illumina MethylationEPIC,0.483,loss,SRR2109876_unaligned.bam,TM66_RL,Thalamus,No,SeqCap_VCRome_v2.1,CS500-CaptureSelect,Roche_NimbleGen_SeqCap_EZ_Exome_v2.0,PerkinElmer,SeqCap_EZ_MedExome,Within Normal Limits,mm_squared,6.3_ng/mL,20-29,CD70-targeted CAR-T Cells,NR,above_14_mg/L,35_minutes,60_min,not_reported,Other,L12-55,Anal_canal,Esophageal,0,Y1999,2020,2.75e6,one_hundred_twenty_eight,ENST00000557334,NR,Cardiac,Gastric,E4512_ALT,600mg,grams_per_day,52_weeks,TSDT_Treatment_Stopped_Due_to_Toxicity,unknown,Prophylaxis,data_missing,14_months,Hematopoietic_Stem_Cell_Transplantation,RFA,14.4_cm3,AML,lymphoma,NR,12.8_mm,4.2_mm,Unknown_Status,Solitary,Grade_4,Grade_3,Sparse,Medium,10.1_cm,Medial_horn,dodecaploid,80%,2_Stable_Disease,Not_Specified,5.2_mm,9.7_cm,publication_release,Petroleum_smoke,Cigarillo,Stage_1A3,T3d,Stage_1A,NR,VII,Absent,Present,7_years,Bilat,Surgical_Repair,NR,2023-12-23T19:40Z,twelve_times,Germline_variant,Transloc,Unknown,UNK,Unknown,term_full,Tumor_weight_>200g,absent,L12,high_coverage,NR,Favorable_Histology,2024-06-12T12:00Z,https://github.com/rna-sequencing/workflow_v12/commit/d6e7f8g9h0,2023-12-07T16:00Z,CNV_Analysis,v6.1.1,MCMXLVI,Y2026,Y2016,Y12,45,CZ,Nullizyg
2.25,CHEK2_N345K,Successful,454_Sequence_Adapter,Dual_index_adapter,Diabetic_nephropathy,NR,Xeroderma,G3,90_years,late_seventies,adolescent,octogenarian,Yes,VHL_variants,HIV_cachexia,M1,N0_molecular_positive,Stage_IV,Ta,NA,N1c,Tis_N0_M0,T3b,VII,four_and_half_days,light,Yearly,U,Infrequent_Drinker,Spirits,Normal_Sample3_Read1.fastq.gz,S13_45612,SV_Adjustment,Small_Fast_Aligner,250ul,650ul,FFPE_lymph_node_biopsy,1.6g,scRNAseq_cluster_data.csv,0.3ng/mL,Neoplastic,Protein,650ul,PD-L1,Generalized,Klinefelter_syndrome,NR,Pyrexia,IV,Unknown,Stage_3,D1228N_MET,CD45_PTPRC,NCI_GDC,Present,Grunerite,thirty-eight point four,750bp,375bp,No,Present,NVIDIA_Parabricks,Guppy_v3.1.5,NA,B1313,YZ13,RD-Resp_Disease,Orchis,L,Dimethyl Sulfoxide,pH_min,albumin_serum_max,obese_class_3,2.83_m2,Present,5.0_mm,Sporadic_BL_general,Early_Detection,Osteogenic_sarcoma,HCM1_3738,Metrics_Change,Not_Otherwise_Specified,NR,AE,four_hundred_twenty,PWID,60K,Genomic_Oncology_Centers,UM RCC,FAM,Glucinum,No,C,RG013_PT_G_TMR,M13-60,H3K27ac_antibody_ab4729,Control,translocation_9_11_p22_q23,22q,NR,non-smoker,70mm,level_1,completed,Concurrent_primary,Fungal Extracts,N/A,Monoclonal,Present,PATHO-23-13,U,Intermediate_Risk,NR,data_not_available,No,End_Stage_Renal_Disease,Clinical_Assessment,15mM,Waiver,NR,6%,11%,IVC,twelve,clinical_annotation_CNV_rtf,LumpySV_Liftover,amplification,Transcriptome Sequencing,Palestine,GT,cycle_13,2024-01-15T07:40Z,2021-03-13 00:00:00,Angela H Brodie,49.9kg,6p22,NGS_Data,Browser_Extensible_Data_Paired_End,Browser Extensible Data,HPV16/18+,RNA_Splice_Junctions,Enzymatic_Activity_Data,180d,26_weeks,-28 years,9_weeks,10_months,two_months,DOD_400,9_months,10_months,18_months,month_6,positive_1_month,8_weeks,13_months,13_months,30_months,-13,day_90,20_weeks,57.1_weeks,16_weeks,PHS000436,Alcohol_Use,IHC_Results,NR,No,No,duodecuple,Non-CR_Non-PD-Stable Disease,Mixed_Stromal_Tumors,Proximal_<=2cm,SUPP-01344RC,eighty-one,jem20191865,Absent,Positive,Cytokine,Severe,Other_Dysplasia,Not_Assessed,Postgraduate_Degree,High_Risk,Yttrium-90_Sirspheres,TwoColor_seq,Unknown,U,E2,NA,NR,Absent,74.9%,checksum_failure,High_Grade_Dysplasia,Yes,Unknown,Imaging_Evidence,Histologic_Confirmation,missing,segment13,dosage_calculation_procedures.txt,EpigeneticAccessibility_HeLa_DMSO,Whole_Genome_Amplification_X,Genome Editing,Transcriptome_Sequencing,Unknown,12h,55_years,Domestic,Silica_Dust,Cardiovascular_Disease,MS_data_analysis,Ext,Not_Assessed,Micro_Ext,Negative,T4b_Very_Advanced,Brunneous,M4_Acute_Myelomonocytic_Leukemia,Gastric_cancer,exp_grp2_read1.fastq,77.4%,83.7%,seventy-eight,seventy-nine,Unk,'88,Ovarian_Cancer_Patient11_Proteome.dat,2MB,IHC_images.zip,Missing,>180D,Neuromotor_Alterations,SEQ34567J8,PD,750bp,eight_hundred_bp,700bp,46.5_SD,NA,Cold alcohol freezing,Yes,UNSPEC,FLT3_ITD,BMP5,Omics_Data_Fusion,Octopus_variant_caller,G4,P4,65%,very_high_grade,Absent,12.6_cm,90000,156_hrs,No,1.73m,Positive_Response,G2,centromere_protein_A,Absent,Pheochromocytoma_Paraganglioma,5000_copies_ml,Unk,Active,Combined_PE,HPV-35,HPV-66,Not_Applicable,Radical_Hyst,Follicular_lymphoma_unspecified,Malignant neoplasm of thyroid gland,pt_root,Not_Available,Gastric,2024-Jan-20,Data_Not_Available,Unknown,significantly_high,18.5,X-ray,TNF_inhibitor,Pending,1,Genomic_Seq_Start,Unknown,85.1_kg,Unknown,Metastatic_Special,Protein_Arrays,2025-Nov-17,373mm,High_Risk,int_13,Group_4,stage_3,Fresh,1,0_None,80_normal_activity_with_effort,Successful,Soluble_Mesothelin-Related_Peptides,L13,not_reported,Unknown_status,NR,2011-08-06T01:54:30+00:00,2021-05-13T18:10Z,icosi,Tumor_Microenvironment_Catalogue,Lexogen 015.96,Illumina Nextera DNA Flex,10x Genomics Inc.,Ribo-Zero Gold RNA-Seq Kit v1.2,Ribosomal_RNA_Removal,US,Transposase-Accessible Chromatin Sequencing,fifteen,octaconta,VHL_3p25.3,33.7cm,Not_Followed_Up,RND,Cervical,Supraclavicular,twelve,fifteen,U,4000x,v13,9_cm,Positive,Renal_Vein,Dissolved,Stage_4A,CGI_14010_Methyl_Inc,R132H_IDH1,Parotid,98f13708210194c475687be6106a3b84_hash,600_fold_coverage,cm,ND,Absent,Unknown,NR,unknown,Peritoneal_Effusion,Prospective_Collection,Sample Integrity Check,low,EpicArray_to_Sequence_Conversion,NR,Positive,v13,miR_pull-down,hsa-miR-200c,Yes,NR,low,2.4k,Unspecified,UTR5_Variant,FLT3 gene mutations,Papillary_pattern,carcinoma_nos,intermediate,MSS,c.35G>A,I_Minimal,two_hundred_fifty_five,Pairwise_Log_Ratio,cshl.edu,82.5%,Absent,Absent,Present,Not_available,No,NR,HMG-CoA_Reductase_Inhibitor,Data_Not_Submitted,Targeted therapy resistance,thirteen_hundred,quadvigint,fifty,two_thousand_one_hundred,30_years,Healthcare Administrator,Unknown,Score_of_Oncotype_DX,Capsule_Ruptured,Indeterminate,Yes,Continuous_Oxygen_Therapy,forty_five,three_sixty,2022,Type_I,Mammary_tissue,Absent,P25,variant_of_uncertain_significance,j1k2l3n5-o6p7-q8r9-s0t1-u2v3w4x5y6,tumor_penetrates_renal_capsule_or_involves_renal_sinus_negative_margins_and_lymph_nodes_with_distant_metastasis,NR,Failure,NR,Failure,NR,13.7%,97.5%,seventy_percent,60.3%,47.1%,48.6%,10.2%,37.9%,7.2%,minimal,60%,29.7%,70.2%,85.0%,94.7%,U,>3,fourteen,Atyp,Pos,Cervical_HPV_Genotyping,M13,NextSeq,NR,PMID_37890123,24-25_servings,dodecaparous,Tubal_Pregnancy,No,Yes,650mg,Optimal_Cutting_Temperature_compound,Medulloblastoma,Positive,G3,Anal_Canal,not_specified,Data_Not_Collected,DNA_analysis_bypassed,NA,Surgical Approaches in Oncology,Not_Collected,Renal_NOS,Regional_Metastasis,Bladder_Cancer_Management_Strategies,SARCOMA-2022-RE_ALT,Programmed_Cell_Death,3.3%,99%,87%,65%,97%,60%,fifteen,seventy_five,60%,BCL2,ALL0031,B_AA,NA,NR,PacBio_SMRT,Seq_Platform,Sequel_II,600bp,NA,Adverse_Events,tredecuple,398mm,NA,combo_therapy,imaging_features.mat,sixties,UNK,Nephroblastoma,Sibling,No,Smoker,unk,twelve,Yes,2024-Jan-15,Y,Published,Not_Applicable,No_Residual_Tumor,R2_macroscopic_residual,>20_mm,Not_reported,v13,60%,Absent,average,1.9,U,Postmenopausal_hormone_use,Gene_Chip_Technology,degraded,Carcinoma,IA,protein_levels.txt,thirteenth,Benign_Tumors,metastatic,extensive,Absent,Positive,C-11 Choline,7.0.3,Ex38,PML_MYLM,Splice_variant_analysis,Grade_1,NR,Ovarian,No,Yes,0,0,Failure,Pass,Crick Inst,2023-Oct-12,COLD SPRING HARBOR,2.2_cm,CDH1_var,Chromothripsis,Chromium_3p_GEX_v2,Larynx_supraglottic,Ovarian,tredecuple,5.9_cm,501-550nm,Mucicarmine_stained_adenocarcinoma,Argentaffin_stain,3:Active_Smoker,PureCN,SomaticSeq,ASCAT,Manta,W110*_CDKN2A,dPCR_for_Mutation_Detection,SpectraMax_Plate_Reader,5 uM,BSA.fasta,18.5%,H_and_E,weak,Foreign_DNA_contamination,Authorized,WHAMSV,MET_skip_mutations,Affymetrix Axiom PanAFR,0.369,high_gain,SRR7890123_unaligned.bam,BM53_SM,UNK,No,SureSelect_CGCI_BLGSP_4.6Mb,TGK850-TargetGen,Agilent_SureSelect_Focused_Exome,BioRad,SureSelect_Human_All_Exon_8,Quantitative Measure Available,mg/dL,12.8_ng/mL,30-39,Cetuximab,NR,>14_milligrams_per_liter,40_minutes,1.5_hours,not_reported,Adj_Therapy,M13-60,Ciliary_body,Thyroidal,1,Y1968,2021,3e6,two_hundred_fifty_six,NM_000314,NR,Cardiac,Vesical,E4512_ALT,650mg,milligrams_per_week,57_weeks,NTM_Normalization_of_Tumor_Markers,unknown,Adjuvant_Therapy,treatment_given,15_months,Excisional_Biopsy,Proton beam therapy,16.0_cm3,WT,neuroblastoma,NR,14.3_mm,5.6_mm,Unknown_Status,Solitary,Low,Not_Reported,Sparse,Medium,12.6_cm,Superior_zone,tridecaploid,70%,3_Progressive_Disease,Not_Specified,6.0_mm,1.8_cm,dataset_iteration,Garbage_burning_smoke,Diverse,Stage_2A,T3d,Stage_1A1,NR,II,Present,NR,8_years,NR,Natural_Resolution,NR,2024-01-07T20:15Z,fifteen_times,Acquired_variant,Inv,IMVI,Hepatitis B Virus DNA,Unknown,postterm,Elevated_mitotic_activity,maximal,M13,low_coverage,G2,NA,2024-07-27T20:15Z,https://github.com/protein-analysis/workflow_v13/commit/i1j2k3l4m5,2023-01-28T10:30Z,miRNA_Sequencing,v7.0.0,MCML,Y2027,Y2017,Y13,50,TZ,Unk
1.60,KRAS_G13C,Successful,MegaRAP_Adapter,Single_index_adapter,High_grade_dysplasia,Present,Dermatologic Disorders,G3,100_years,mid_eighties,adolescent,nonagenarian,Y,NF1_variants,CMV_retinitis,M1b,N2,Stage_IV,DCIS_Tis,NA,N1b_II,NR,T2a,III,five_and_half_days,light,Yearly,Yes,Frequent_Drinker,Spirits,Normal_Sample3_Read2.fastq.gz,S14_56723,SNV_Standardization,Velvet_Assembler,4000ul,700ul,Fecal_matter,1.8g,radiomics_analysis.xls,5.5ng/mL,Aberrant,Messenger_RNA,700ul,Lactate_Dehydrogenase,Generalized,Klinefelter_syndrome,NR,Additional_symptoms,III,No,Stage_3,FLT3_internal_tandem_duplications,CD33_SIGLEC3,COSMIC,U,Grunerite,twenty-four point one,800bp,400bp,No,Present,Somatic_Sniper,Albacore_v1.0.0,NR,B1414,XY14,MR-Min_Response,Vesica Urinaria,Unk,Y-27632,O2Sat_min,eosinophil_count_high,normal_weight,2.94_m2,Present,5.5_mm,ID-associated_BL_pediatric,Monitoring,Glioblastoma_multiforme,HCM1_4041,QC_Failure,Not_Otherwise_Specified,Unk,Deceased,two_hundred_sixty,Blood_Product_Recipient,65K,Radiation_Cancer_Centers,COHCCC,FAM,Oxirane,Yes,Unknown,RG014_PT_G_NRM,N14-65,H3K27ac_antibody_ab4729,Control,translocation_3_5_q25_q34,9q,NR,non-smoker,75mm,level_3,confirmed,Different_type,"Trans-3,5,4'-trihydroxystilbene",N/A,Monoclonal,Absent,RADIO-23-14,II,Unknown,U,not_reported,No,Inflammatory_Bowel_Disease,Not_Reported,20mM,Waiver,Y,6.5%,13%,Adrenal_Gland,thirteen,event_logbook_CNV_odt,TITAN_CopyNumberAlteration_Liftover,amplification,Genome Editing Screening,Serbia,FR,cycle_14,2024-02-20T22:15Z,2021-03-14 00:00:00,Brian Druker,73.2kg,8q24,SNPs,Array_Data_Format,Generic Feature Format,FLT3-ITD AML,Patient_Metadata,Cellular_Morphology_Data,210d,28_weeks,-34 years,10_weeks,11_months,three_months,DOD_435,10_months,12_months,20_months,month_7,positive_3_months,9_weeks,14_months,14_months,33_months,-14,day_105,22_weeks,62.1_weeks,20_weeks,PHS000437,Exercise_Frequency,Chemotherapy_Results,DPP-4_Inhibitor,Yes,Data_Not_Collected,tredecuple,RD-Responsive,Mixed_Stromal_Tumors,Remote_>2cm,SUPP-01455EC,seventy,s41388-020-1274-6,NR,Positive,Cytokine,Unknown,Esophageal_Columnar_Dysplasia,Data_Missing,Secondary_Education_Incomplete,NR,Polyvinyl_Alcohol_Particles,SMRT,Unknown,NR,NR,M2,Absent,Present,80.5%,checksum_failure,Low_Grade_Dysplasia,No,Not_Collected,Imaging_Evidence,Histologic_Confirmation,missing,segment14,specimen_preparation_instructions.docx,LysosomeActivity_MDA231_CQ,DNA_Isolation_Chemical_Method,Single-Cell Analysis,Bisulfite_Sequencing,Unknown,14h,60_years,Domestic,General_Dust,Chronic_Autoimmune_Gastritis,Epigen_mod_analysis,Ext,Not_Assessed,Micro_Ext,Yes,T4a_Moderate_Advanced,Corylus,M6_Acute_Erythroid_Leukemia,Hepatic_cancer,exp_grp2_read2.fastq,69.7%,65.4%,ninety-nine,fifty-four,Unk,'88,Skin_Cancer_Sample12_messengerRNA.gff,4MB,Drug_Response_Data.csv,Missing,0-30D,NR,SEQ45678K9,SD,800bp,eight_fifty_bp,750bp,51.7_SD,Unknown,Carbon dioxide freezing,Yes,NR,ALK_translocation,RECQL4,Transcript_Assembly,SAMtools_mpileup,G4,P4,70%,low_grade,Absent,13.8_cm,55400,168_hrs,Unknown,1.8m,No_Response,G2,Not_Specified,Absent,Pheochromocytoma_Paraganglioma,7500_copies_ml,Unk,Past,Estrogen_mono,HPV-59,HPV-39,Macro_Parametrium,Hysterectomy_UNSPEC,Acute_lymphoblastic_leukemia,Malignant melanoma of skin unspecified,subject_root,Unfavorable,Vesical,2024-Feb-17,Pulmonary_Metastasis,Unknown,peak,20.1,MRI,Not_Reported,0,1,Genomic_Seq_Start,NR,90.4_kg,Unknown,Localized_1,Affy_SNP6,2026-Jan-20,406mm,Low_Risk,int_14,Group_2C,stage_4,Fresh,1,Not_Reported,20_very_poor,Warning,Soluble_Mesothelin-Related_Peptides,L14,micro,Distant_metastasis_not_reported,L,2010-05-22T03:35:45+00:00,2022-07-19T20:35Z,icosipent,Cancer_Microbiome_DB,Takara 634888,Agilent SureSelect XT2,Zymo,QIAseq DNAseq Library Kit v4,Sequence_Capture,NA,Whole Exome Sequencing,twenty,nonaconta,FLT3_13q12.2,36.5cm,Not_Followed_Up,RND,Left_axillary,Pelvic,thirteen,twenty,Absent,5000x,v14,10_cm,Positive,Gerotas_Fascia,Dissolved,Stage_1,CGI_15175_Methyl_Dec,W288*_NPM1,Parotid,3c59dc048e8850243be8079a5c74d079_hash,650_fold_coverage,cm,ND,NR,Post-menopausal,Unk,distant_met,Pulmonary,Prospective_Collection,Missing Data Estimation,moderate,EPIC_to_hg38_Methylation_Liftover,NR,Positive,v14,FirePlex_analysis,hsa-miR-141,U,Moderate,high,1.3k,STR_analysis,UTR5_Variant,IDH1/2 gene analysis,Solid_growth,carcinoma_nos,low,Microsatellite_stable,c.37G>A,IV_Severe,two_hundred_eighty,Loss_of_Het,icr.ac.uk,90%,Absent,Missing,Absent,Not_available,No,NR,Acetylsalicylic_Acid,Data_Not_Submitted,Hospice care initiated,fourteen_hundred,trigint,fifty_five,two_thousand_four_hundred,35_years,OT,Not_Embedded,Status_of_BRCA_Mutations,Capsule_Fragmented,Absent,NR,On-Off_Oxygen_Therapy,fifty,four_twenty,2023,Type_I,Lymphatic_tissue_biopsy,NR,P30,pathogenic,k5l4m3o1-p0q9-r8s7-t6u5-v4w3x2y1z0,tumor_biopsy_only_no_distant_metastasis,Failure,Successful,NA,Warning,UNK,1.8%,99.1%,seventy_two_percent,65.7%,5.6%,52.1%,14.8%,40.5%,4.8%,moderate_low,65%,36.2%,80.0%,90.8%,97.5%,U,>3,sixteen,Atyp,NR,MultipleMyeloma_IgH_Rearrangement,N14,FACSymphony,Hyperdiploidy,PMID_38901234,26-27_servings,tridecaparous,Tubal_Pregnancy,No,Yes,700mg,Cryo,Nevus,Negative,G4,Urinary_Tract,not_specified,Data_Not_Collected,DNA_analysis_bypassed,NR,Post-Treatment Survivor Support,Unknown,Digestive_system_overlapping_lesion,Unknown,Sarcoma_Molecular_Characterization,THYROID-RES-15_ALT,Self-Digestion,3.5%,88%,86%,70%,84%,65%,eighteen,eighty,75%,MET,NCT008605,Unknown,NR,Ukn,Bio-Rad_ddPCR,Lib_Strategy,iSeq_100,650bp,NA,Physician_Decision,quattuordecuple,432mm,Surgical_Intervention,rescue_therapy,immune_profiles.xml,twenties,UNK,Myeloid_Leukemia,M_Great_Aunt,No,Smoker,unk,thirteen,Yes,2024-Feb-20,Y,Not_Published,Not_Applicable,NR,R1_microscopic_residual,10-20_mm,Not_reported,v14,65%,Absent,average,7.8,Present,Genetic_anomalies,bDNA_Assay,highly_degraded,Melanoma,IC,snp_genotyping.aff,fourteenth,Pleural_Fluid,primary_blood_derived,none,Absent,Uncertain,F-18 NaF,7.7.7,Ex41,LYL1_LYLF,Tumor_mutational_load_analysis,Grade_3,Absent,Cervical,Yes,Yes,Included,0,Failure,Failure,CSHL,2023-Nov-05,LEVINE CANCER INSTITUTE,4.7_cm,NF1_var,Chromoplexy,SmartSeq2,Not_Otherwise_Specified,Vesical,quattuordecuple,1.4_cm,551-600nm,Fontana_Masson_stained_melanoma,AO_staining,5:Status_Unknown,MSIsensor_microsatellite,DeepVariant,PyClone,DELLY,FLT3_internal_tandem_duplication,Phosphoprotein_Profiling,DU_800,10 uM,Synth_Oligos.fasta,27.7%,H_and_E,weak,Transportation_delay,Authorized,MoChA,VHL_mutation_analysis,Illumina HiSeq,0.822,slight_loss,SRR3210987_unaligned.bam,CS11_TN,Spinal_cord,No,SureSelect_CGCI_BLGSP_4.6Mb,PCX500-PureCapture,ThermoFisher_Ion_Torrent_AmpliSeq_CCP,Merck,Nextera_Flex_Enrichment,Elevated,cells_per_mL,0.5_ng/mL,20-29,XmAb2513,Absent,>14_milligrams_per_liter,45_minutes,2_hours,not_reported,Adj_Therapy,N14-65,Bladder_posterior_wall,Vesical,No,Y2008,2022,3.25e6,forty_nine_k_one_fifty_two,NM_001256849,NR,CSF,Renal,A081801_ALT,700mg,milligrams_per_kilogram,61_weeks,VGPR_Very_Good_Partial_Response,qw,Adjuvant_Therapy,treatment_given,16_months,Radiomodification_Therapy,T-cell transfer therapy,18.5_cm3,AML,glioma,NR,15.7_mm,8.4_mm,Pre-cancerous,Solitary,Grade_X,Grade_3,Abundant,Medium,14.2_cm,Inferior_zone,tetradecaploid,60%,3_Progressive_Disease,Pedunculated,7.3_mm,3.3_cm,version_update,Cannabis_smoke,Cigarillo,Stage_1A,T0,Stage_1B1,TX,VII,Present,Absent,9_years,Lt,Orchidectomy,L,2024-02-17T14:55Z,twenty_times,Germline_variant,Del,Macrovascular_Invasion,HBV Genotype Analysis,Unknown,postterm,Reticulin_network_loss,absent,N14,high_coverage,G2,Anaplastic,2024-08-09T09:00Z,https://github.com/cell-signaling/workflow_v14/commit/n6o7p8q9r0,2023-02-15T15:45Z,ABSOLUTE_LiftOver,v7.4.5,MCMLIV,Y2028,Y2018,Y14,55,PZ,Hemizyg
2.30,CDKN2A_P13L,Successful,SureSelect_Adapter,Multiplexing_adapter,High_grade_dysplasia,Absent,Myasthenia,G1,100_years,late_seventies,adolescent,octogenarian,N,IDH1_variants,Not_otherwise_specified,Unknown,N2c,Stage_IV,T1b,NA,N1b_II,NR,T1b,VII,six_and_half_days,none,Weekly,U,Frequent_Drinker,Spirits,Metastatic_Sample2_Read1.fastq.gz,S15_67834,Indel_Alignment_Adjustment,MUltiple_Sequence_Comparison_by_Log-Expectation,6000ul,750ul,FNA,2g,immune_seq.fasta,7.2ng/mL,Adjacent_to_Tumor,Protein,750ul,Carbohydrate_Antigen_19-9,Positive,Triple_X,NR,Diaphoresis_nocturnal,III,Yes,Stage_3,W288fs_NPM1,CD7_T-Cell_Surface_Marker,TARGET,U,Grunerite,thirty-three point seven,850bp,425bp,No,NR,Platypus_variant_caller,Bonito_v0.3.1,Successful,B1515,ZA15,PPD-Pseudo_Progression,Dorsum,L,Hydrocortisone Hemisuccinate,Glu_min,bilirubin_total_max,overweight,3.05_m2,NR,6.0_mm,Sporadic_BL_adult,Monitoring,Leukaemia,HCM1_4344,QC_Failure,Cause_Unknown,Vital_Records,Deceased,five_hundred_ninety,Missing_Data,70K,Surgical_Cancer_Centers,VICC,VIC,Propenamide,U,Not_Reported,RG015_PT_H_TMR,O15-70,NA,H3K9trimethylation,Not_Reported,22q,long_arm,non-smoker,80mm,level_1,completed,Initial_primary,Magnesium Citrate,T,Monoclonal,Present,SURGI-23-15,IV,Low_Risk,I,intermediate_risk,No,Chronic_Pancreatitis,Not_Reported,25mM,Waiver,N,7%,14%,Renal,fourteen,pathway_analysis_CNV_mdb,Sequenza_CNALiftover,amplification,CNV Analysis Pipeline,Israel,GU,cycle_15,2024-03-05T05:55Z,2021-03-15 00:00:00,Gordon Freeman,67.8kg,12p13,NGS_Reads,Browser_Extensible_Data_Paired_End,Apache Parquet,del(17p) CLL,CN_Levels_By_Gene,Exposomics_Data,240d,6_weeks,-18 years,1_week,1_year,four_months,DOD_470,1_year,4_months,2_years,month_2_half,positive_6_months,10_weeks,15_months,15_months,36_months,-15,day_120,10_weeks,12.9_weeks,24_weeks,PHS000438,Nutrition_Habits,Radiotherapy_Reports,UNK,Yes,Unknown,quattuordecuple,TE-Early Evaluation,Giant_Cell_Neoplasms,NA,SUPP-01566HC,one hundred five,jci129448,Absent,NR,Cytokine,Severe,Other_Dysplasia,3_Capable_of_only_Limited_Selfcare,Secondary_Education_Completed,Not_Specified,Ethiodized_Oil,MinION,IA,M0,E2,M2,Absent,Absent,87.2%,checksum_failure,High_Grade_Dysplasia,Yes,Not_Hispanic_Latino,Imaging_Evidence,Histologic_Confirmation,missing,segment15,experiment_outcomes_report.pdf,CellularAging_BJ_TGFa,Ancient_DNA_Isolation,PGx,Protein_Expression_Array,Unknown,16h,65_years,Passive,Coal_Dust,Hyperandrogenism,Transcript_assembly_annotation,Ext,Not_Assessed,Micro_Ext,Yes,T3_Minimal,Rubious & Violaceous,M7_Acute_Megakaryoblastic_Leukemia,Endometrial_cancer,biopsy_sC_read1_001.fastq,83.6%,79.6%,eighty-five,ninety-six,Stage_II,'88,Pancreatic_Cancer_Patient13_SingleNucleotidePolymorphism.h5,8MB,CellLine_Genotyping_data.txt,Disease_Progression,0-30D,NR,SEQ56789L0,Palliative_consultation,850bp,nine_hundred_bp,800bp,39.4_SD,Unknown,Immersion freezing,Yes,U,NPM1_alterations,CLTCL1,Epigenomic_Mapping,Canvas_SV_detection,G2,P4,75%,low_grade,NR,15.0_cm,40700,180_hrs,Unknown,1.9m,U,G2,H3Y,NR,Pheochromocytoma_Paraganglioma,10000_copies_ml,Unk,Past,NR,HPV-33,HPV-33,Urinary_Bladder,Hysterectomy_SPEC,Malignant_melanoma_of_skin_unspecified,Malignant neoplasm of endometrium,pt_root,Intermediate,Cervical,2024-Mar-12,No_Abnormality_Detected,Unknown,peak,22.4,CT_scan,Cyclophosphamide,Completed,1,Dx,Residual_Dx,95.7_kg,NR,Unknown,Affy_SNP6,2026-Mar-15,438mm,Low_Intermediate_Risk,int_15,Group_4,stage_4,Paraffin-Embedded,No,Not_Reported,90_minor_signs_or_symptoms,Successful,Serum_Creatinine,L15,macro_>2cm,Biochemical_recurrence_not_reported,NR,2009-03-09T05:17:00+00:00,2023-02-15T07:40Z,icositriantal,Precision_Oncology_Library,Twist Bioscience 101031,Twist Bioscience Exome,Promega Corporation,SMART-Seq v4 Ultra Low Input RNA Kit,Sequence_Capture,NA,Ribonucleic Acid Sequencing,twenty-five,centi,ESR1_6q25.1,39.8cm,NA,MRND,Right_axillary,Common_iliac,fourteen,twenty-five,Absent,6000x,v15,15_cm,NR,Renal_Hilum,Single,Stage_4A,CGI_16340_Stable,ITD_FLT3,Splenic_nodes,1f0e3dad99908345f7439f8ffabdffc4_hash,700_fold_coverage,cm,U,NR,Peri-menopausal,Unk,not_rptd,Spinal,Prospective_Collection,Experimental Noise Reduction,high,Cross-Platform_Methylation_Normalization,Unknown,Unk,v15,miRNA_seq,hsa-miR-29c,Yes,NR,moderate,1.1k,NR,CDS_Variant,MGMT promoter methylation status,Cribriform,adenoma_benign,high,Microsatellite_stable,c.37G>A,IV_Severe,three_hundred_five,coding_region,gustaveroussy.fr,97.8%,Absent,Missing,Present,Not_available,No,NR,Acetylsalicylic_Acid,Data_Unknown,Post-diagnosis lifestyle modification,fifteen_hundred,triacontahex,sixty,two_thousand_seven_hundred_fifty,40_years,Nutritionist,Embedded,Status_of_TP53_Mutation,Capsule_Ruptured,Indeterminate,Yes,On-Off_Oxygen_Therapy,sixty,thirty,2024,Type_II,FNA_biopsy,Absent,P35,variant_of_uncertain_significance,l6m7n8p0-q1r2-s3t4-u5v6-w7x8y9z0a1,tumor_confined_kidney_no_distant_metastasis,Warning,NA,Passed,NA,WARNING,10.2%,100%,seventy_five_percent,70.9%,70.4%,55.5%,1.9%,45.0%,1.3%,none,70%,11.0%,90.8%,97.3%,99.1%,U,>3,eighteen,Atyp,Neg,SoftTissueSarcoma_TP53_Test,O15,QuantStudio,Tetraploidy,PMID_39012345,28+_servings,tetradecaparous,NR,Y,NR,750mg,Formalin_Fixed_Paraffin_Embedded,Meningioma,Negative,G3,External_Female_Genitalia,Data_Not_Collected,Unknown,DNA_analysis_bypassed,Gastrointestinal_Scopy,Diet & Recovery in Oncology,No,Abdominal_soft_tissues,Regional_Recurrence,Thyroid_Cancer_Signaling_Pathways,OVARIAN-2023-PR_ALT,Cell_Proliferation_Disorder,3.8%,96%,85%,75%,98%,70%,twenty,eighty_five,90%,VEGFA,NCT009340,NA,Absent,NR,Qiagen_PyroMark,Read_Pair_Orient,PromethION,700bp,Read2,Physician_Decision,quindecuple,465mm,Medical_Management,investigational_therapy,public_health_data.mdb,thirties,M,Myeloid_Leukemia,Sibling,No,Smoker,unk,fourteen,Yes,2024-Mar-05,Y,Not_Available,Enabled,No_Residual_Tumor,R2_macroscopic_residual,10-20_mm,Not_reported,v15,70%,Absent,above_average,9.2,U,Immune_system_suppression,MERFISH_Technology,nearly_unusable,Neuroblastoma,Nasal,gut_microbiota.fasta,fifteenth,Excluded_Sample,normal_tissue,minimal,Present,Positive,C-11 Choline,8.0,Ex44,PML_MYLM,Proteomics,Grade_2,Absent,Cerebral,No,Yes,Included,No,NR,Failure,HudsonAlpha Inst,2023-Dec-20,VICTORIAN COMPREHENSIVE CANCER CENTRE,0.7_cm,RB1_var,Ring_chr,Chromium_3p_GEX_v2,Colon_transverse,Thyroidal,quindecuple,7.0_cm,>600nm,Orcein_stained_hepatoma,Wright-Giemsa_stain,5:Status_Unknown,GATK_HaplotypeCaller,Platypus,SCHISM,GRIDSS,V617F_JAK2,TMA_analysis,Epoch,20 uM,Custom_Fragments.fasta,43.9%,H_and_E,very_strong,Data_entry_error,Authorized,FusionCatcher,IDH1_R132H_variant_screening,Thermo Fisher QuantStudio 3D Digital PCR,0.945,gain,SRR8901234_unaligned.bam,IP22_PO,Frontal_lobe,No,TruSeq_Cancer_Panel,ST100-SeqTarget,Illumina_TruSeq_Custom_Enrichment,GenScript,AmpliSeq_HD_Custom_Panels,Elevated,g/dL,10.4_ng/mL,76-100,Cetuximab,Absent,above_14_mg/L,50_minutes,3_hours,not_reported,Post_Surgery_3M,O15-70,Respiratory_system_ill_defined,Cervical,0,Y1980,2023,3.5e6,ninety_eight_k_three_oh_four,NM_017617,NR,Axillary,Osseous,E4512_ALT,750mg,milligrams_per_milliliter,61_weeks,NR_No_Response,qw,Primary_Therapy,treatment_given,17_months,Unknown_Therapy,Biological therapy,20.7_cm3,AML,leukemia,NR,11.2_mm,9.1_mm,Initial,Solitary,Grade_X,Grade_3,Intermediate,High,15.8_cm,Parietal_lobe,pentadecaploid,50%,3_Progressive_Disease,Infiltrative,8.1_mm,10.4_cm,publication_release,Cigarette_smoke,Diverse,Stage_2C1,Tis_DCIS,Stage_1A1,T4,VI,Present,Present,10_years,Bilat,Natural_Resolution,Bilat,2024-03-09T09:45Z,twenty_five_times,Acquired_variant,Ins,EMVI,Hepatitis B Virus DNA,LTFU,term_full,Cellular_uniformity,low,O15,very_high_coverage,G2,NR,2024-09-03T17:30Z,https://github.com/mutation-analysis/workflow_v15/commit/s1t2u3v4w5,2023-03-23T12:30Z,Structural_Variant_Aggregation,v8.0.0,MCMLVIII,Y2029,Y2019,Y15,NA,CZ,Homozyg
